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Background: Prenatal exposure to substances, including alcohol, opiates and illicit drugs, 
may influence a child’s neurodevelopment and possibly impact on their subsequent 
mental health. Maternal use of substances is an increasing public health problem, and it is 
difficult to obtain a true estimate of the prevalence of prenatally substance-exposed 
children, partly due to stigmatization and the illegal nature of substance use. Alcohol has 
well-known teratogenic effects, and its prenatal exposure is associated with fetal alcohol 
spectrum disorders (FASD), with the development of neurodevelopmental impairments 
across the lifespan, including an increased risk of various mental health problems. In 
contrast, less is known about the long-term consequences of prenatal exposure to 
substances other than alcohol, and previous studies examining its possible effects on 
neurodevelopment and mental health have shown mixed results, although some studies 
have reported neurodevelopmental impairments persisting into school age and later into 
adolescence. It is difficult, however, to distinguish between the possible effects of 
prenatal substance exposure and those of other factors associated with a child’s 
neurodevelopment and mental health such as genetic and environmental factors, including 
the caregiving environment. 
 
Objective: The objective of this study was to assess mental health and investigate the 
care situation and use of supportive measures in a hospital-based population of school-
aged children prenatally exposed to alcohol and other substances, compared to a reference 
group. 
 
Methods: This study included children, aged between 6 and 14 years, with prenatal 
substance exposure who were referred to the Department of Pediatrics at Haukeland 
University Hospital in Bergen, Norway, from January 1997 to December 2012. Referral 





history of prenatal exposure to substances. Children with confirmed prenatal exposure to 
substances, including alcohol, illicit drugs, illegal use of prescription drugs, and opioids 
used in opioid management treatment programmes (OMT), were included in the study. Of 
a total number of 128 children referred, 87% (n = 111) gave informed written consent and 
were included in the study. Based on the mother’s main substance of use during 
pregnancy, children were systematically categorized into two groups: (1) prenatal 
exposure to alcohol (FASD group); and (2) prenatal exposure to other substances. 
Information on the care situation and use of supportive measures was obtained from the 
children’s medical records, and relevant questionnaires were completed by their 
caregivers.  Mental health was assessed using three different standardized questionnaires: 
(1) the Strength and Difficulties Questionnaire (SDQ); (2) the Swanson, Nolan and 
Pelham Questionnaire, revision IV (SNAP-IV); and (3) the Autism Spectrum Screening 
Questionnaire (ASSQ), which were completed by children’s current caregivers. For 
mental health assessment, outcomes were compared to a reference group derived from the 
population-based Bergen Child Study (BCS). 
 
Results: Of 111 children prenatally exposed to substances, 50 (45%) children were 
prenatally exposed to alcohol and 61 (55%) to other substances. More than half (59%) 
were boys, and 86% were living in foster care, of whom 30% were placed into foster care 
during their first year of life. In addition, 92% of the children in foster care had additional 
supportive measures, including reinforced foster care, school and/or social support. In the 
assessment of mental health using the SDQ, 105 children completed the questionnaire and 
were included in this part of the study. SDQ subscale mean scores, total difficulties scores 
and total impact scores were statistically significantly higher in the group of exposed 
children, compared to the reference group, indicating a higher rate of mental health 
problems in the exposed group, as well as problems in more than one domain of mental 





children mainly exposed to alcohol and the group mainly exposed to other substances. 
Further evaluation of mental health problems associated with social skills challenges, 
hyperactivity and inattention was performed for the group of children exposed to 
substances other than alcohol, using the SNAP-IV and ASSQ. The children’s caregivers 
reported an increased number of symptoms associated with attention-deficit/hyperactivity 
disorder (ADHD) in the areas of both inattention and hyperactivity/impulsivity, as well as 
a higher number of symptoms associated with autism spectrum disorders (ASD), 
compared to the reference group. 
 
Conclusion: In this hospital-based population of children prenatally exposed to alcohol 
and other substances, the children were found to have an increased risk of mental health 
problems affecting their daily life functioning, when compared to a reference group. The 
mental health problems present were not restricted to one specific area, but rather 
represented problems in more than one domain of mental health. Children mainly exposed 
to substances other than alcohol were found to have an increased level of symptoms 
associated with ASD and ADHD in the areas of inattention and hyperactivity/impulsivity. 
A high proportion of the prenatally exposed children lived in adoptive homes or in foster 
care. Children in foster care often had supportive measures, in addition to their placement 
outside their biological home. The high level of use of care and supportive measures 
could be a reflection of the children’s increased care and support needs, which, in turn, 
may be associated with an increased risk of mental health problems in the group of 
substance-exposed children. Further research is needed both on diagnostic investigation 
of mental health problems and on determining the care and support needs in children 
prenatally exposed to substances. 
 
Clinical implications: Because of the increased risk of mental health problems associated 





exposed to substances should prove beneficial. In addition, children’s caregivers should 
be aware of the range of mental health problems that exposed children are at risk of, and 
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1.1 Fetal development and prenatal substance exposure 
Prenatal exposure to substances may influence neurodevelopment, and subsequent mental 
health, in children (1-6). Through their pharmacological properties, many substances are 
able to cross the placental barrier which serves as the interface regulating the transfer of 
materials between maternal and fetal circulations (6, 7). Placental passage of substances 
depends on various substance-related factors, including the molecular size and charge, 
protein-binding properties and lipid solubility (7, 8). In addition, any effects on the fetus 
as a consequence of substances crossing the placental barrier also depend on maternal 
factors, including metabolic and genetic factors, which may cause individual differences 
in both maternal and fetal substance uptake and elimination (7, 8). 
Any exogenous substance that crosses the placental barrier has the potential to 
disrupt the normal and tightly regulated fetal neurodevelopment (9, 10). Substances can 
act either directly on molecular targets in the fetus or indirectly on the fetus through 
effects on the placenta or uterus (11). Alcohol, opiates and illicit drugs, including 
amphetamine, cocaine, cannabis and benzodiazepines, all have the pharmacological 
potential to rapidly enter the fetal circulation, and fetal exposure to these substances can 
adversely impact on fetal development (3, 5, 6, 12-14). 
During the first 8 weeks of gestation, termed the embryonic period (10), the basic features 
of organs and body systems of the human embryo are established, along with significant 
embryonic growth and maturation during this period to reach the fetal stage of 
development (10). It has been postulated that fetal development is marked by critical time 
points that correspond to normal organ formation and development (10, 15). Thus, the 
risk of malformations and developmental impairments due to prenatal substance exposure 
may differ at different time points during pregnancy. Development of the central nervous 
system (CNS), including the brain, begins early during the embryonic period and continue 





differentiation and apoptosis (10, 15). However,  full maturation of the brain is not 
completed until after birth (10), with further brain development and modulation 
continuing throughout childhood and adolescence (15). The postnatal growth of the brain 
involves not only an increase in size, but also neuronal proliferation and myelination. 
Importantly, the process of neuronal organization and interconnections is highly complex 
and under strict control via different mechanisms (10). It is known that both pre- and post-
environmental factors can influence neurodevelopment (15), as brain plasticity is related 
to its responses to different experiences. Thus, several studies showed an association 
between brain development and function and various environmental factors such as drug 
exposure, early stressors, hormonal influences, sensory stimuli and parent–child 
relationships (16). 
Previous research found an increased risk of neurodevelopmental impairments and mental 
health problems in association with prenatal substance exposure (2, 3, 6, 12, 17, 18). 
Moreover, established risk factors for mental health problems include genetic and 
environmental factors such as the caregiving environment (19). However, it is difficult to 
distinguish between the possible effects of prenatal substance exposure and those of 
established or unknown factors on a child’s neurodevelopment and mental health. The 
aims of the present study were to assess mental health and investigate the care situation 
and use of supportive measures in a population of school-aged children prenatally 
exposed to alcohol and other substances, compared to a reference group.  
 
1.2 Prenatal exposure to alcohol and other substances 
Maternal substance use is defined as use of alcohol, prescribed or illicit use of opiates, use 
of illicit drugs and use of illegal prescribed psychoactive substances. Use of these 





Alcohol comprises a large group of organic compounds containing a hydroxyl 
group, of which ethanol found in liquor, wine and beer is one example (21). In this 
context, and for the purpose of this thesis, the term alcohol is used to refer to ethanol. 
Alcohol exerts well-known teratogenic effects, with the potential to cause 
congenital malformations and/or abnormal neurobehavioural manifestations later in life 
(22). Possible long-term effects of prenatal exposure to substances other than alcohol are 
less well established (2, 6). In view of this, it was considered appropriate, in this study, to 
distinguish between exposure to alcohol and exposure to substances other than alcohol 
when examining the effects of prenatal substance exposure. 
Maternal substance use is a common public health problem worldwide. In the 
United States and Western European countries, the incidence of prenatal substance 
exposure has been rising over the past decade (23, 24). However, given the stigmatization 
associated with, and the illegal nature of illicit drug use, it is difficult to obtain a true 
estimate of the prevalence of substance-exposed children (6, 21, 25). These, together with 
underreporting of maternal substance use, have hampered efforts in setting up population-
based studies to investigate the prevalence of prenatal substance exposure.  
 
1.2.1 Prevalence of prenatal alcohol exposure 
According to an American national survey on drug abuse and health in 2014, 10.8% of 
pregnant women consumed alcohol during pregnancy (6, 25, 26). In a European cross-
country study, almost 16% of pregnant women consumed alcohol during pregnancy, with 
Norway presenting with one of the lowest estimates at 4.1% (27). The study demonstrated 
large variations between the participating countries, which could be explained by 
differences among countries in terms of sociocultural and socio-economic factors, 
legislation and public health advice and awareness campaigns from national health 
authorities (27). A recent systematic review and meta-analysis found a prevalence of 





differences between populations, while other studies on the prevalence of FASD also 
reported large differences in prevalence across geographical and cultural populations (28, 
29). 
 
1.2.2 Prevalence of prenatal exposure to substances other than alcohol 
Similarly to the prevalence of alcohol use, estimating the prevalence of opiate use and the 
illicit use of substances is challenging. According to an American national survey on drug 
abuse and health in 2014 (26), approximately 4% of pregnant women reported the use of 
illicit drugs during pregnancy. It was also shown that the incidence of neonatal abstinence 
syndrome (NAS) is increasing in the United States (5.8 per 1000 hospital births), as well 
as in other Western countries, suggesting an increased rate of prenatal opiate exposure 
(30, 31). 
The World Health Organization (WHO) recommends opioid management 
treatment programs (OMT) for opioid-addicted pregnant women. Increasingly more 
women of childbearing age are enrolled in OMT, and this can possibly affect the 
increasing rate of NAS. According to the Norwegian health authorities, it is expected that 
about 30–60 children are born to mothers participating in OMT in Norway every year 
(32). 
 
1.2.3 Children with prenatal alcohol exposure 
The deleterious consequences of prenatal alcohol exposure were described in as early as 
the 1970s, and it is well established that alcohol exposure during pregnancy can adversely 
affect the fetal CNS and neurodevelopment in different ways (33). In animal studies, 
alcohol has been found to exert a direct toxic effect on neurons, by inhibiting neuronal 
cell division and proliferation and disrupting the process of neuronal migration and 
neuronal network formation in the developing brain (34). These toxic effects at a cellular 





head circumference and craniofacial structural malformations, as well as cognitive 
impairment and learning disabilities. 
 Different terms have been used to describe the effects of prenatal alcohol exposure. 
FASD is one of the most recent terms in use (33) and therefore will be applied throughout 
the remaining course of this thesis. It has been shown that prenatal alcohol exposure may 
result in FASD (6, 17, 33). FASD comprises a spectrum of conditions presenting with 
mild to severe neurodevelopmental consequences, such as cognitive impairment and an 
increased risk of specific learning disabilities and mental health problems including 
attention-deficit/hyperactivity disorder (ADHD), anxiety, mood disorders and autism 
spectrum disorders (ASD), as well as growth restriction and dysmorphic features, with 
fetal alcohol syndrome (FAS) as the most severe consequence (6, 17, 33, 35). The 
diagnostic criteria of FAS, based on the Centers for Disease Control and Prevention 
(CDC) criteria, include: (1) the presence of facial dysmorphic features (smooth philtrum, 
thin vermilion border, small palpebral fissures); (2) growth restriction (pre- or postnatal 
height or weight ≤10th percentile); and (3) CNS impairment (structural, neurologic or 
functional abnormalities) (33). Differential diagnoses need to be considered in cases of 
suspected FAS, because the dysmorphic features present in FAS can also be observed in 
other syndromes (e.g. Williams syndrome and Dubowitz syndrome) (33). FASD is not a 
diagnostic term, but rather an umbrella term encompassing several diagnostic terms used 
to describe the full range of all possible effects of prenatal alcohol exposure (36). 
Other important sequelae associated with prenatal alcohol exposure include an 
increased risk of miscarriage, preterm birth, pre- and postnatal growth restriction and 
sudden infant death syndrome (SIDS), as well as effects on various organ systems such as 
the cardiovascular, musculoskeletal, renal, ocular and auditory systems (6, 35). 
The degree of impact of maternal alcohol use on fetal development depends on a 
variety of factors, including the timing and level of alcohol exposure and genetic 





exposure to alcohol has suggested a link between the genetic background, environmental 
factors and neurodevelopmental outcomes (36, 37). 
 
1.2.4 Children with prenatal exposure to substances other than alcohol 
Substances other than alcohol include illicit drugs (e.g. heroin, amphetamine, cocaine and 
cannabis), prescription drugs such as benzodiazepines and opiates used illegally and 
opioids used in OMT. Prenatal exposure to these substances has been associated with 
preterm birth, low birthweight, small head circumference and withdrawal symptoms after 
birth (6, 38, 39). Of note, children prenatally exposed to opiates, in particular, are at risk 
of developing NAS (23, 30, 38), which has been found in 55–94% of children prenatally 
exposed to opioids (23, 30, 38, 40). 
NAS is a complex disorder involving the CNS and gastrointestinal system, as well 
as metabolic and respiratory disturbances. Clinical manifestations range from mild 
symptoms, such as sneezing, irritability, hypertonia, mild tremors, sweating and poor 
feeding, to severe symptoms such as seizures, excessive weight loss, hyperthermia and 
respiratory disturbances (23, 30, 38). In addition, a recent follow-up study of children 
with NAS reported an increased risk of rehospitalization for maltreatment, trauma and 
mental health problems, compared to controls (4). 
Systematic reviews of children prenatally exposed to substances other than alcohol 
found an increased risk of cognitive and behavioural impairments at preschool age (2, 5). 
Furthermore, several longitudinal studies found that cognitive difficulties as a result of 
prenatal substance exposure in preschool-aged children persisted into school age and 
adolescence. A recent study described increasing effects over time of prenatal substance 
exposure, compared to non-exposure, on cognition (2, 18, 41, 42), as well as an increased 






Moreover, a review of neuroimaging studies of children prenatally exposed to 
substances highlighted findings from studies that showed smaller brain volumes and 
altered brain metabolic activity following prenatal substance exposure (43). A previous in 
vitro study of human neuronal cells showed that opiates promoted apoptotic cell death, 
suggesting a possible impact on fetal brain development (44). In addition, a recent animal 
study described an association between prenatal exposure to opiates and long-term 
behavioural changes related to cognitive function (45). However, results are conflicting, 
and further research on long-term consequences, including mental health outcomes, of 
prenatal exposure to substances other than alcohol is needed (5). 
 
1.3 Mental health 
Mental health is defined by the WHO as: “a state of well-being in which every individual 
realizes his or her own potential, can cope with the normal stresses of life, can work 
productively and fruitfully, and is able to make a contribution to her or his the 
community” (46). 
In contrast, the term “mental health problems” is difficult to define as a distinct 
entity. Rather the term includes a continuum of symptoms, some of which will meet the 
diagnostic criteria for a psychiatric disorder (47). The diagnosis of a psychiatric disorder 
implies the presence of symptoms over a certain time period, and having an impact on 
daily functioning (20, 48). Approximately 8–10% of the general child population is 
diagnosed with a psychiatric disorder. In addition an increasing proportion of children are 
presenting with mental health problems without fulfilling the diagnostic criteria for any 
particular psychiatric disorder (20, 49-51). For the general child and adolescent 
populations, the prevalence of different mental health problems normally varies with age 
and gender (52). 
Previous studies found an association between prenatal substance exposure and an 





as emotional problems like anxiety and mood disorders, and externalizing problems 
related to harmful and disruptive behaviour (2, 6, 53, 54). Of particular relevance to this 
present study is an increased risk of mental health problems among children in foster care 
(50, 55). In a Norwegian sample, Lehmann et al. found that one in two children in foster 
care had a psychiatric disorder (55), with the most common mental health problems being 
emotional disorders, behavioural disorders and ADHD. In addition, nearly one in five 
children were diagnosed with reactive attachment disorder (RAD), with a high 
comorbidity rate for emotional disorders, behavioural disorders and ADHD (55). The 
authors also found an increased risk of mental health problems associated with exposure 
to violence, serious neglect and the number of prior placements into foster care (55). 
 
1.3.1 Emotional problems 
Emotional problems include symptoms of anxiety and depressive disorders (20, 48). It is 
found that girls experienced more emotional problems than boys, especially during 
adolescence (56). A review of studies of psychiatric conditions associated with prenatal 
alcohol exposure described an increased risk of emotional problems and mood disorders, 
such as depression and anxiety, across the lifespan (14). Moreover, other studies reported 
an increased risk of emotional problems in children exposed to substances other than 
alcohol (2, 57), with a higher rate of emotional problems among girls with such exposure 
reported by Irner et al. (2014) (18). 
 
1.3.2 Conduct problems 
Conduct problems include oppositional defiant disorder (ODD), conduct disorder (CD) 
and disruptive behaviour disorder. An increased risk of behavioural disorders in children 
prenatally exposed to alcohol and to substances other than alcohol has been reported 





FASD had approximately five times higher risk of ODD and three times higher risk of 
CD, compared to the general population (54). 
 
1.3.3 Inattention, impulsivity and hyperactivity 
The three core symptoms of ADHD are inattention, hyperactivity and impulsivity (20). In 
Norway, approximately 3% of children are diagnosed with ADHD, predominantly among 
older children and boys (61). ADHD is a complex disorder and may result from processes 
including both genetic and non-genetic factors, with possible involvement of 
neurobiological factors such as structural brain factors and neurotransmitters in the brain 
(15, 62, 63). Several studies have found an increased risk of ADHD in children prenatally 




1.3.4 Social skills challenges 
Social skills challenges, including peer problems, are related to problems with social 
interaction and communication, as well as restricted behaviour (20), all of  which may 
relate to symptoms of Autism  Spectrum Disorders (ASD). ASD comprise a range of 
symptoms, of which social impairments are the core symptom (64). The prevalence of 
ASD has been estimated to be just under 1%, with a predominance among boys (61). In 
recent years, there has been a rise in the prevalence, although any reasonable explanation 
has proven elusive (64). 
A recent study found that prenatally alcohol-exposed children have a twofold 
higher risk of ASD, compared to the general population (54). However, there seems to be 
a lack of studies on the relationship between prenatal exposure to substances other than 






1.3.5 Reactive attachment disorder 
Reactive attachment disorder (RAD) is characterized by social impairments (20, 48, 65). 
Whereas ASD is considered as a neurodevelopmental disorder, RAD is a disorder which 
may result from inadequate caregiving and can develop when a child’s caregiving 
environment fails to establish and meet the child’s care needs (20, 48, 65). Parental 
substance use is associated with an increased risk of child maltreatment and placement 
into foster care. Therefore, prenatally substance-exposed children may be at risk of 
inadequate caregiving conditions and foster care placement, which, in turn, would 
increase their risk of RAD. 
 
1.4 Mental health problems and risk factors 
Mental health problems are associated with several risk factors other than prenatal 
substance exposure, including genetic and epigenetic factors (15, 66), gender (52, 56), 
cognitive functioning (67, 68), socio-economic factors and environmental conditions, 
including caregiving environment (50, 53, 55, 60, 69-71). These risk factors will be 
discussed in more detail in the following sections. 
 
1.4.1 Genetic and epigenetic factors 
Genetic factors seem to play a significant role in a child’s development and in the risk of 
acquiring certain mental health disorders. Children whose parents have ADHD are more 
likely to develop ADHD, probably due to a combination of both genetic and non-genetic 
factors (15, 62, 63).  
The field of epigenetics attempts to explain how different environmental factors 
and experiences can impact on genetic expression. One proposed definition of epigenetics 
is: “An epigenetic trait is a stable heritable phenotype resulting from changes in a 
chromosome without alterations in the DNA sequence” (72). Based on this definition, it 





child’s genetic expression, either through effects of individual factors or through an 
interaction between the various factors (36, 73, 74). There is growing evidence of an 
association between life stressors in early childhood and subsequent emotional mental 
health problems (75, 76). This may be related to stress hormones, e.g. in the dysregulation 
of the hypothalamic–pituitary–adrenal (HPA) axis, acting as epigenetic factors (36, 75, 
76). This illustrates the complexity in understanding risk factors in relation to others. 
 
1.4.2 Cognitive functioning 
Cognitive impairment is another risk factor for mental health problems (67, 68). It has 
been shown previously that lower cognitive functioning is related to an increased risk of 
mental health problems (67, 68). In addition, Sameroff et al. found that an increasing 
number of environmental risk factors was associated with a decrease in intelligence 
quotient (IQ) scores (77). 
Concerning the risk of cognitive impairment in prenatal alcohol exposure, previous 
studies reported an association between prenatal alcohol exposure and cognitive 
impairments, including lower IQ (33). In contrast, other studies in children exposed to 
substances other than alcohol found the IQ to be within the normal range for this group 
(2, 78). 
 
1.4.3 Socio-economic status 
Low socio-economic status (SES) is a well-established risk factor for mental health 
problems (79), including both internalizing and externalizing problems (80, 81). The 
presence of a substance use disorder is associated with a low SES, which may increase the 
risk of mental health problems in children prenatally exposed to substances who are living 






1.4.4 Caregiving environment 
Parents’ ability to function as caregivers can be severely impaired by their use of 
substances, which is a risk factor for their children’s placement into foster care (21, 55). 
As mentioned in Section 1.4.3, parental substance use increases the risk of low SES, 
which exposes families to an increased risk of poverty, family stress, low level of parental 
education, poor prenatal care and family instability (55, 83, 84). Use of substances during 
pregnancy is associated with a higher risk of poor maternal nutritional status and 
infections, along with possible impact on fetal development. For opioid-dependent 
pregnant women attending OMT, these risks have been found to decrease, indicating that 
OMT contributes to improved prenatal care in opioid-dependent pregnant women (85, 
86). 
Exposure to inadequate caregiving conditions early in life may affect mental health 
later in life. The prevalence of mental disorders in youth placed into foster care in 
Western countries has been estimated to be almost threefold higher than that in the 
general population (55, 87). Moreover, some studies in prenatally exposed children found 
that optimizing care conditions is likely to have a positive effect on cognitive and mental 
health outcomes (55, 69, 88). 
Children born with NAS have special care needs related to their health issues. Neonates 
with NAS have greater care needs, compared with newborns without NAS, particularly in 
terms of feeding problems, extensive crying and sleep disturbances. Therefore, there 
could be a potential mismatch between a child’s care needs and the biological parents’ 







Figure 1. Potential mismatch between biological parents’ caregiving abilities and the 
prenatally substance-exposed child’s care needs. 
 
Norwegian Child Welfare Services and the provision of supportive measures 
Under Norwegian law, a child’s biological parents are responsible for the provision of all 
necessary care and protection to meet the child’s daily needs. If, for some reason, the 
biological parents are not able to provide the care required, the Child Welfare Services, 
which are responsible for child welfare protection in Norway, are legally obligated to 
intervene in order to ensure adequate care for the child, including supportive measures 
within or outside the biological home, temporary or permanent foster care placement or 
adoption (89). The Child Welfare Services are obliged to act in the best interests of the 
child at all times, even in cases where the parents and child’s interests are in conflict (89, 
90). Furthermore, the Child Welfare Services have to consider voluntary interventions 
before making any decision on initiating measures without parental consent (90). 
 According to official Norwegian statistics (2016) nearly 4% of all children and 
adolescents aged 0–22 years receive some kind of supportive measures from the Child 
Welfare Services, including foster care (90, 91). Of those children receiving supportive 
care, 40% live outside their biological home, the majority of whom are in foster care (90, 
Parental caregiving abilities  
Prenatally substance-exposed 





91). In Western societies, including Norway, about five in 1000 children are placed into 
care outside their biological home (89, 90, 92). 
 
1.5  Prenatal substance exposure and risk of mental health problems 
In summary, earlier research suggest that children prenatally exposed to alcohol and other 
substances are likely to be more vulnerable to developing mental health problems, with 
several associated risk factors which can be either cumulative and/or interacting (83, 93) 
(see Figure 2). For substances other than alcohol, results are more conflicting. It is 
possible that risk factors in the caregiving environment may have a greater impact on a 
child’s development than prenatal substance exposure itself (83, 93). However, it is also 
possible that prenatal substance exposure affects neurodevelopment, and consequently the 
child’s vulnerability to environmental factors. A possible cumulative effect of biological 





























Regardless of the risk factors influencing mental health outcomes in prenatally substance-
exposed children, there remains a need for in-depth knowledge and understanding of the 
types, especially the specific areas, of mental health problems that can affect these 
children, in order to define and facilitate the provision of appropriate and adequate 





2. Aims  
The overall aim of the work presented in this thesis was to investigate the long-term 
outcomes related to the care situation and mental health status in a hospital-based 
population of school-aged children prenatally exposed to alcohol and other substances. 
The study objectives were as follows: 
 Paper I: to investigate the care situation of prenatally substance-exposed children 
and the level of use of supportive measures in their home and school settings; 
 Paper II: to evaluate the overall mental health status of prenatally substance-
exposed children, compared to a reference group, using the Strength and 
Difficulties Questionnaire (SDQ), which is a standardized mental health screening 
instrument; 
 Paper III: to determine the mental health symptoms associated with particular 
domains of ADHD and ASD in children exposed to substances other than alcohol, 
compared to a reference group. 
 
2.1 Study hypothesis 
The work presented in this thesis was based on the following proposed hypotheses: 
 
 The hospital-based population of children prenatally exposed to substances have an 
increased risk of foster care placement or of provision of school support or other 
supportive measures; 
 The hospital-based population of children prenatally exposed to substances have an 
increased risk of mental health problems in one or more domains of mental health, 





 Based on the known teratogenic effects of alcohol, children prenatally exposed to 
alcohol have increased mental health problems and care and supportive measures, 






The work presented in this thesis was part of the project “Children prenatally exposed to 
substances: growth, health and development”, initiated and led by Dr. Med. Liv Marie 
Lægreid and Prof. Dr. Med. Irene B. Elgen, Department of Pediatrics and Department of 
Child and Adolescent Psychiatry at Haukeland University Hospital, which was conducted 
from 1997 to 2012. 
The study described in this thesis was divided into three parts, with each part 
presented in its respective published research article denoted in this thesis as “Paper I”, 
“Paper II” and “Paper III” (see List of publications). 
 
3.1 Study participants 
The project was based on a follow-up study including a hospital-based population of 
children who were referred to the Department of Pediatrics at Haukeland University 
Hospital in Bergen, Norway between January 1997 and December 2012. Study 
participants were aged ≥14 years at the point of data collection, with the oldest child aged 
14.5 years/174 months. 
Referral criteria included the presence of developmental impairments and a 
concomitant past medical history of prenatal alcohol or other substance exposure. 
Children transferred to Department of Pediatrics with symptoms of NAS after birth were 
also included in the study. Referrals were from health-care providers, social workers and 
physicians in primary community care units and paediatric and child psychiatric units. 
During the recruitment period, the children’s caregivers were invited to participate 
in the study by a letter of invitation containing information about the study. In addition, 
for those children in foster care, a letter detailing information about the study was sent to 
the social services agency responsible for the child. It was possible to accept participating 
in the entire study, or in parts of the study such as assessment of the care situation, 





In Norway, children normally start at school in August in the year of their sixth 
birthday, although in some cases, children can be under 6 years old. A total of 128 
children aged between 6 and 14 years were invited to participate in the study, including 
one child aged under 6 years. Of the 128 eligible children, 111 (87%) gave informed 
written consent and participated in the study, as follows (see Table 1): 
 Paper I: all 111 children completed the relevant questionnaire for the work 
presented in this paper; 
 Paper II: of the 111 participating children, 105 (95%) had their caregivers complete 
the SDQ; 
 Paper III: of the 111 participating children, 61 were mainly exposed to substances 
other than alcohol, and of those 61 children, 57 (93%) completed the Swanson, 
Nolan and Pelham Questionnaire, revision IV (SNAP-IV) and Autism Spectrum 



















Table 1. Number of participants in the paper I, II and III.  
Total number of eligible children prenatally exposed to substances, N = 128 
(age 6–14 years: defined as 6–14.5 years, i.e. 72–174 months) 
Number of children who gave informed written consent, n = 111 (87%) 
Paper I 
Care and Supportive 
measures (n = 111) 
Paper II 
SDQ 
(n = 105) 
Paper III 
ASSQ + SNAP-IV 
(n = 57) 
Children prenatally exposed 
to substances 
(n = 111)¹ 
 111 completed the 
questionnaire and were 
included 
Children prenatally 
exposed to substances 
(n = 111)¹ 
 105 (95%) completed 
the SDQ and were 
included²  
Children mainly exposed to 
substances other than 
alcohol (n = 61/111)³ 
 57 (93%) completed the 
SNAP-IV and ASSQ 
and were included 
¹Including 50 children with FASD and 61 exposed to other substances,  
²Excluding six children with missing SDQ,  
³Excluding 50 children with FASD 
 
3.2 Participant categorization according to prenatal substance 
exposure 
Children with confirmed prenatal exposure to substances, including alcohol, illicit drugs, 
illegal use of prescription drugs, and opioids used in OMT, were included in the study. 
History of exposure was confirmed by information obtained from the mothers and 
obstetric or paediatric records, including data from referring units and medical reports of 
neonatal withdrawal symptoms after birth. Data were systematically recorded based on 
the mother’s main drug of use during pregnancy, and the children were categorized into 
two groups: (1) prenatal exposure to alcohol (FASD group); and (2) prenatal exposure to 





substance used in pregnancy, including the number of units of alcohol consumed, or the 
exact timing of exposure during pregnancy. 
If there was evidence of exposure to both alcohol and other substances, the child 
was placed in the FASD group, provided alcohol was the main substance of use by the 
mother, clinical evidence of FASD, and reports of regular, or more often than occasional, 
episodes of alcohol use during pregnancy. Also, if a child met the clinical criteria of FAS, 
the child was placed in the FASD group. Therefore, no children in the other substances 
group met the FAS criteria. 
 
3.2.1 Fetal alcohol spectrum disorders (FASD) 
The FASD group included cases of both FAS and FASD. The diagnosis of FAS or FASD 
was given after evaluation of the medical history and clinical examination by a 
paediatrician with relevant specialized training and neuropsychological testing. 
Differential diagnoses were considered in all cases, and paediatricians specially trained in 
the field, including paediatric endocrinologists and geneticists, were consulted in cases of 
uncertain diagnosis. FAS was diagnosed if a child with confirmed prenatal alcohol 
exposure met all of the following CDC criteria (33): (1) presence of facial dysmorphic 
features; (2) growth restriction; and (3) CNS impairment. Children with confirmed 
alcohol exposure who only fulfilled some, but not all, of the three FAS criteria were 
categorized into the FASD group. 
CNS impairment was defined as the presence of learning disabilities (defined as an 
IQ score below 85) or a diagnosis of ADHD. Intellectual level was determined using 
either the Wechsler Preschool and Primary Scale of Intelligence (WPPSI) test (95)  or the 
Wechsler Intelligence Scale for Children-Revised (WISC-R) test (96). An IQ score below 
70 was defined as intellectual disability, and an IQ score of 70–84 as low IQ. ADHD was 
diagnosed by a paediatrician and a child psychiatrist according to the International 






3.2.2 Prenatal exposure to substances other than alcohol 
This group included children exposed to street drugs and polydrug use, as well as those 
exposed to opioids as part of the national OMT. The most common “other substances” 
reported in this group were opiates and polydrug use. Children in this group either had a 
medical history of prenatal exposure to one or more other substances or were diagnosed 
with NAS after birth. None of the children in this group met the criteria for FAS. 
Although non-documented (i.e. unknown) use of alcohol could not be totally excluded, 
the mother’s main drug of use included substances other than alcohol. 
 
3.2.3 The reference group 
The reference group consisted of children participating in the Bergen Child Study (BCS), 
which is a longitudinal population-based study. There were no exclusion criteria, and all 
children attending grades 2–4 at 79 schools in a geographically delineated area in the 
academic years of 2002 and 2003 were invited to participate in the study (n = 9430) (51). 
Parent SDQs were completed for about two-thirds of the participating children (n = 6297) 
(51). Of the participating children in the BCS, about two out of three lived in a family 
categorized as having good or very good family economy, and about 50% of the mothers 
and fathers had higher education (80). More details about the reference group are 
presented in the papers by Heiervang et al. (2007) (51, 80, 97), Boe et al. (2012) (51, 80, 
97) and Stormark et al. (2008) (51, 80, 97). In the present study, participants from the first 
two waves were included. The first wave of the BCS, was conducted in autumn 2002,  
and informed consent to participate was received from 7007 (74%) parents prior to study 
inclusion. The second wave was conducted 4 years later during spring 2006, comprising 
5683 children aged 11–13 years (60% of the original target population). For every 
participating child in the hospital-based group of children prenatally exposed to 





(± 0.9 years), were randomly selected into the reference group. Three controls were 
included for each case to improve the robustness of the analyses (98). As age was 
considered to be an important matching factor in the present study, a relatively narrow 
matching criterion of ± 0.9 years was used, which hence allowed three eligible controls 
from the BCS. A 3:1 ratio was considered to work best with the available data, since to 
achieve a 4:1 ratio between the controls and cases would require the age matching 
criterion to be extended to about ± 2 years. 
 
3.3 Ethics 
The study was approved by the Regional Committee for Medical Research Ethics in 
Norway (REK-West 2010/3301). For children prenatally exposed to substances, informed 
written consent was obtained from all participating caregivers, including the biological 
parents for children living in their biological home or, alternatively, the foster parents for 
children living in foster care. For children in foster care, the social welfare office legally 
responsible for the participating child also gave written content. In addition to the 
caregivers and social welfare office, children above 12 years of age also gave their 
independent consent to participate in the study. For the reference group, the caregivers 
gave informed written consent. 
 
3.4 Measures and assessment 
3.4.1 Withdrawal symptoms and neonatal abstinence syndrome 
Children’s symptoms compatible with withdrawal were recorded, and the abstinence 
symptoms were scored using a modified version of the Finnegan abstinence score (38). If 







3.4.2 Care situation 
Based on medical records and the questionnaires completed by the children’s respective 
caregivers, the following data were obtained: 
(a) Current care status—biological or adopted family, or foster care (including foster 
homes and foster care institutions); 
(b) For children living outside their biological home: age at their first placement and 
the total number of placements. 
With regard to foster care, in the Norwegian foster care system, a temporary foster 
home is normally provided until a permanent home is found. More than two foster care 
placements can be related to disruptions in foster homes and unintentional placements 
between foster care situations (99). 
If a child had moved out of their biological home before 1 year of age, placement 
outside the biological home was categorized as early placement. 
 
3.4.3 Supportive measures and reinforced foster care 
 
Supportive measures 
In addition to the caregiving status, information on other supportive measures was also 
obtained. “School support” was defined as services from the Educational Psychological 
Service (EPS), as well as other academic support. “Social support” was defined as weekly 
counselling and support given by a social worker or paid personal support contact for 
recreational activities. “Additional home” (i.e. outside the foster home) at leisure time 
was recorded, e.g. weekend/visiting homes, in addition to the foster home. A combined 
variable “Any support” was also assessed, based on all the measures mentioned above, 
comprising at least one or more supportive measures, including reinforced foster home. 
 





Data on placement into reinforced foster homes or institutions were collected. In a 
reinforced foster home, one foster parent is compensated financially for caregiving in the 
home during daytime. For further reinforcement, children can be placed in a child welfare 
institution. Only two children were placed in an institution, and they were therefore 
categorized as being placed in a reinforced foster home for the purpose of the study 
analyses. 
 
3.4.4 Cognitive functioning 
Cognitive functioning in the exposed children was evaluated using either the WPPSI (95) 
or the WISC-R (96). 
 
3.4.5 Mental health 
Mental health assessment was based on three different standardized questionnaires: SDQ, 
SNAP-IV and ASSQ. All questionnaires contained items scored on a 3-point scale (i.e. 0, 
1, 2). The questionnaires were completed by the child’s current caregiver. 
 
3.4.5.1 The Strengths and Difficulties Questionnaire (SDQ) 
The SDQ is a general behavioural screening questionnaire for 4- to 17-year-olds and 
consists of 25 items describing positive and negative attributes of the children (100-102). 
In this study, the SDQ was completed by the children’s caregivers. The SDQ is widely 
used in groups at-risk, such as children with chronic illness, those with intellectual 
disabilities and those prenatally exposed to substances (18, 103-105). The use of the SDQ 
as a screening instrument for mental health disorders in foster children has been 
previously validated (106). 
The SDQ is divided into five subscales: (1) emotional problems; (2) hyperactivity 
problems; (3) conduct problems; (4) peer problems; and (5) prosocial behaviour. For 





mental health problems (102). In this study, the emotional problems subscale, including 
questions on anxiety and depressive symptoms, was used to assess emotional symptoms. 
Furthermore, a total difficulties score (TDS) was computed by adding the first four 
subscale scores. Each item was scored on a 3-point scale, i.e. “not true”, “somewhat true” 
and “certainly true”, with total subscale scores ranging from 0 to 10 and TDS from 0 to 40 
(102). 
The impact supplement of the SDQ is activated by a positive response to one 
screening item, indicating difficulties in areas of emotions, concentration, behaviour or 
social skills. The impact supplement of the SDQ examines overall distress and social 
impairment at home, with friends, at school and in leisure activities. Each item is rated on 
a 4-point scale, rating difficulties as “not at all”, “only a little”, “quite a lot” and “a great 
deal”. This is summed to a total impact score, with a maximum score of 10. If the child is 
not considered to have any impairments, the impact score is 0 (102). The SDQ has been 
demonstrated to have good psychometric properties (101, 105). 
 
3.4.5.2 The Swanson, Nolan and Pelham Questionnaire, revision IV (SNAP-IV) 
The SNAP-IV is a screening tool for ADHD (107). It contains nine items on inattention 
and nine items on hyperactivity/impulsivity, which correspond to the Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria for ADHD (20). 
The reliability of SNAP-IV has been reported as good (108). Scores range from 0 to 18 
for each scale. The SNAP Combined is calculated after summing the two scales, with the 
combined scores ranging from 0 to 36. 
 
3.4.5.3 The Autism Spectrum Screening Questionnaire (ASSQ) 
The ASSQ consists of 27 items reflecting the symptoms of ASD, i.e. social interaction, 
communication, restricted and repetitive behaviour, motor clumsiness and tics (109-111). 





not included (110). Scores range from 0 to 52. In cases where the questionnaire was 
completed by parents, it was recommended to proceed with a diagnostic workup of ASD 
if the total ASSQ score was 17 or higher (111). Based on this, the ASSQ scores were 
dichotomized into high (≥17) and low scores (<17). 
For 21 of the children in the exposed group, one or more answers on the ASSQ 
were missing. For missing data, the variables were replaced with imputed data based on 
the expectation–maximization method, and the ASSQ sum scores computed. 
 
3.5 Statistical analysis 
The questionnaire for obtaining data on the children’s care situation and supportive 
measures was developed specifically for the study, and standardized assessment tools for 
mental health (i.e. SDQ, SNAP-IV and ASSQ) were included as part of the questionnaire. 
All questionnaires were optically read and checked for errors, and questionnaire data were 
recorded manually. 
Statistical analyses were performed using the Statistical Package for the Social 
Sciences (SPSS), version 22 for Papers I and II, and version 24 for Paper III (112). The 
statistical significance level was set at p ≤0.05. 
Where possible, missing data on the questionnaires were completed or corrected 
using information from the child’s medical records. For missing items on the mental 
health assessment forms, the variables were replaced with imputed data based on the 
expectation–maximization method, and sum scores were computed after missing data had 
been imputed (113). This was only applicable to missing items on the ASSQ (in which 
case other assessment tools were completed). 
 For descriptive analyses, frequencies, means and standard deviations (SD) were 
used to describe the sample. Group differences were analysed using independent t-test 
and chi-square test [p-value, odds ratio (OR) and 95% confidence interval (CI)]. Levene’s 





unequal, the t-test not assuming equal variances was used (114). Effect sizes were 
estimated by Cohen’s d, and standard interpretation was used (0.20 = small, 0.50 = 
moderate and 0.80 = large) (115). 
 
3.5.1 Regression analyses 
For the work presented in Paper I, binary logistic regression analyses, including covariate 
variables, were performed to adjust for the age at first placement into foster care. 
For Paper II, a stepwise regression analysis for the substance-exposed group was 
performed, with the SDQ TDS as the dependent variable and gender, age, IQ, drug group 
and care situation as independent variables. Information about care situation and IQ was 
not available for the reference group. The Mann–Whitney U test was also used to assess 
the statistical significance when comparing the groups. This test is suitable for small-sized 
samples and where the distribution is not normal. 
For Paper III, it is recommended to proceed with a diagnostic workup of ASD if 
the total ASSQ score is 17 or higher (111). Based on this, the ASSQ scores were 
dichotomized into high (≥17) or low (<17) scores, and a cut-off value of ≥17 was used to 
compare child placement outside the biological home before or after 1 year of age. Due to 
skewness in outcome variables in the reference group, the maximum likelihood robust 
(MLR) estimator, together with the program Mplus version 7.4 (116), was used for 
sensitivity analyses in order to compute corrected standard errors when testing group 
differences (117, 118). This analysis strategy does not assume equal variances when 
comparing the groups. When analysing the correlation between SNAP-IV and ASSQ 
scores, Spearman correlation was used. 
In the sample of children prenatally exposed to substances, multiple regression 
analysis was used to predict the level of outcome variables SNAP Combined, SNAP 
Inattention and SNAP Hyperactivity/Impulsivity, and ASSQ Total score, Social 





child placement outside the biological home before or after 1 year of age. The predictors 
for mental health outcome were based on earlier studies of prenatal substance exposure 
and mental health in children. 
 
3.5.2 Power analyses 
Power analyses were not performed prior to the study. All eligible children were invited 
to participate in the study. It is possible that some results could have been reported 





4. Summary of results 
4.1 Paper I: Care and supportive measures in school-aged children 
with prenatal substance exposure 
Of the 111 participating children, 50 were categorized in the alcohol-exposed group and 
61 in the group of other substances. 
The majority of children (86%) were living in foster care, including eight of the 
nine children born to mothers who participated in OMT; 11% were adopted, and 3% lived 
with their biological parents. Of the children in foster care, 66% had three or four foster 
care situations, and 15% had five or more foster care situations. The majority of children 
in foster care (70%) were placed after 1 year of age, with an increased risk of more than 
three foster care situations, compared to the group of children placed before 1 year of age 
(OR 3.7, 95% CI 1.2–11.9; p = 0.001). 
Of the children in foster care, the vast majority (92%) received one or more 
supportive measures in their foster home and/or at school. Three out of four children 
received one or two supportive measures, and one out of four received three supportive 
measures. The most common supportive measure was school support, received by the 
majority of children in foster care. Seven children in foster care had no additional 
supportive measures, of whom five were placed into foster care during their first year of 
life. More than one in four of the participating children were in reinforced foster care. 
Substance exposure (alcohol or other substances), gender, number of placements and age 











4.2 Paper II: Mental health in school-aged children prenatally 
exposed to alcohol and other substances 
Of 105 children exposed to substances, 48 were exposed to alcohol (i.e. had FASD) and 
57 were exposed to substances other than alcohol. The majority of the children (86%) 
lived in foster care or in adopted homes (12%). In the FASD group, 42% of the children 
were assigned a diagnosis of FAS. The mean IQ score was significantly higher (p = 
0.001) in the group exposed to substances other than alcohol, compared to the FASD 
group. 
SDQs for all the 105 children were completed by their caregivers, mean scores for 
all five SDQ subscales, TDS and total impact scores were statistically significantly higher 
for both the alcohol- and other substances-exposed groups, compared to the reference 
group. A large effect size was obtained for all subscales and TDS (d ≥0.80), with the 
greatest difference noted for the hyperactivity subscale (d = 2.29). 
When comparing the FASD group and the other substances group, no statistically 
significant differences were found in any of the five SDQ subscale scores, TDS or total 
impact scores. There were no differences in mean scores for any of the SDQ subscales 
between the nine children born to mothers participating in OMT and the other 48 children 
in the group exposed to substances other than alcohol. 
Among the children living in foster care, there were no statistically significant 
differences in the mean TDS between those taken in foster care at birth, those placed 
before 1 year of age and those placed after 1 year of age (mean TDS 17, 18 and 20, 
respectively; p = 0.30). Only the IQ could explain some of the variances in TDS, among 
the variables of age, gender, IQ, substance group and care situation (adjusted R
2
 = 0.06, 







4.3 Paper III: Symptoms associated with ADHD and ASD in school-
aged children prenatally exposed to substances 
Of the children mainly exposed to substances other than alcohol, 57 children completed 
the relevant questionnaires. All, except one child, lived in foster care (n = 54) or with 
adopted parents (n = 2), and of the children adopted or in foster care (n = 56), more than 
one in three were placed outside their biological home before the age of 1 year. 
Symptoms compatible with neonatal abstinence were reported in 41 of the exposed 
children, of whom 18 were diagnosed with NAS. 
Regarding mental health status, caregivers of children in the exposed group 
reported significantly more symptoms associated with ADHD in areas of both inattention 
and hyperactivity/impulsivity. Furthermore, caregivers reported more symptoms 
associated with ASD, compared to the reference group, using the ASSQ. Of the exposed 
children, 37% had high scores (≥17), compared to 3% in the reference group (OR 17.44, 
95% CI 6.1–49.6; p <0.05). There was no significant difference in high ASSQ scores 
between the exposed group of children taken into foster care before and those after 1 year 
of age (p = 0.083). 
 Of the available predictors for mental health outcomes in the exposed group, the 
IQ was a significant predictor for some of the mental health outcomes, and NAS for 
inattention as part of ADHD. Child placement outside the biological home before or after 
the age of 1 year did not affect the results. 
When exploring a possible correlation between ASSQ Total score and SNAP, a 
moderate to strong relationship was found between high scores on ASSQ and high scores 
on SNAP, with the strongest correlation between ASSQ Social difficulties and both 







Results from this study conducted in a hospital-based population of school-aged children 
prenatally exposed to alcohol and other substances, suggest that exposed children are at 
an increased risk of mental health problems in different domains. These children have an 
increased risk of placement either in adopted homes or into foster care and, in addition to 
their out-of-biological home placement, are often provided with supportive measures, 
including school and social support. 
 
5.1 Generalizability 
In this hospital-based study, the study population included children referred to the 
hospital with neonatal abstinence symptoms, or developmental impairments later in 
childhood, and a concomitant past medical history of prenatal substance exposure. It is 
expected that the hospital-based study design and selection of study participants would 
most likely have a great impact on the generalizability of the study findings. 
Generalizability is related to the validity of findings from a particular study in a setting, 
and for a population different from the setting and population in that study (119). It is 
possible that the children represented in this present study were the most severely affected 
in the group of exposed children, and that any exposed children with normal functioning 
were not represented. Moreover, children with severe developmental impairments 
referred to the hospital could have had unknown prenatal substance exposure and not 
have been included in the study. In general, recruitment of representative population 
groups for studies of children prenatally exposed to substances can prove challenging, due 
to the stigmatizing and illegal nature of substance use, which makes it difficult to identify 
the whole group of exposed children in a population. 
Therefore caution should be taken when interpreting the present findings, the 





discussion of the results on mental health problems and care situation below. The more 
general strengths and limitations are described in more detail in Section 5.3. 
5.2 Prenatal substance exposure 
Information about substance exposure was based solely on medical records and history, 
with no toxicology testing of the mothers during pregnancy or of the children after birth. 
This meant that the exact nature of substance exposure during pregnancy was difficult to 
establish. Moreover, it was not possible to ascertain that mothers to children categorized 
in the group of prenatal exposure to substances other than alcohol had not consumed any 
alcohol, in addition to other substances, during their pregnancy, and vice versa. Data 
collection relied on obstetric and paediatric records, as well as reports from mothers. In 
cases showing confirmation or evidence of a greater number of single episodes of alcohol 
exposure, the children were categorized in the FASD group. Because it was not possible 
to verify the accuracy of the types of substances to which the fetus was exposed from the 
information reported by the mothers, there is a potential risk of underestimating the actual 
prenatal exposure to specific substances (120, 121). 
Alcohol is a well-known teratogenic substance. Earlier studies found an increased 
risk of mental health problems, including ADHD, specific learning disabilities, anxiety, 
mood disorders and ASD in children prenatally exposed to alcohol (3, 17, 33, 35, 54) (3, 
17, 33, 35, 54), and findings presented in this thesis are in line with previous research (2, 
6, 17, 54). 
In contrast, previous studies have produced conflicting results on the effects of 
prenatal exposure to substances other than alcohol on mental health (6, 12, 122). 
However, an increased risk of ADHD among children prenatally exposed to substances 
has been reported, and some studies have found an increased risk of mental health 
problems when evaluating emotional and behavioural problems (2, 6, 12, 18), in 





increased risk of problems related to ADHD in areas of both inattention and 
hyperactivity/impulsivity, as well as social skills challenges, in the substance-exposed 
group. A recent study also found an increased risk of ASD in children with FASD (54). 
The results of the present study showed an increased risk of symptoms associated with 
ASD, especially with respect to social difficulties, in the group of children prenatally 
exposed to substances other than alcohol. 
Both ADHD and ASD are complex disorders with neurobiological components 
likely to play an essential role in the underlying mechanisms (123). It is possible that 
prenatal exposure to substances other than alcohol leads to neurobiological vulnerability, 
thus increasing the risk of neurodevelopmental disorders. However, genetic predisposition 
has also been proposed as a risk factor for ADHD, which could explain the increased 
number of ADHD symptoms in children with prenatal exposure to substances other than 
alcohol (63). It has been reported that adults with a substance use disorder have a higher 
rate of ADHD symptoms, and ADHD itself is found to be an independent risk factor for 
substance abuse (62). Thus, prenatally substance-exposed children may be genetically 
predisposed to ADHD, which could possibly explain the increased level of ADHD 
symptoms in this group of children. In the present study, information about parents’ 
mental health was not available.  
 
5.3 Mental health problems 
Symptoms of mental health problems presented in the exposed group of children 
compared to a reference group, were overall increased and not restricted to one category 
of mental health problems, suggesting an increased risk of developing problems in several 
domains or areas.  
Mental health was assessed using the standardized questionnaires SDQ, SNAP-IV 
and ASSQ, thus increasing the robustness of data obtained, as well as study 





IV and ASSQ) are not diagnostic tools, but rather screening tools of mental health and 
diagnostic assessment was not performed.  
Furthermore, the increased risk of symptoms associated with ASD in children exposed to 
substances other than alcohol does not necessarily reflect a high prevalence rate of the 
diagnosis. ASD is characterized by symptoms of social impairment. However, other 
mental health disorders, such as RAD, have overlapping symptoms (20, 48). The present 
study used the ASSQ as a screening tool for symptoms associated with ASD and did not 
include a diagnostic assessment in the study population. Thus, the high ASSQ symptom 
scores could be related to ASD, RAD or other disorders or conditions associated with one 
or more of the risk factors in the exposed group. Therefore, diagnostic assessment is 
necessary to distinguish between these disorders and confirm a potential diagnosis. 
5.4 Care situation 
The fact that RAD could be associated with increased ASSQ scores is an important point 
to consider, since RAD could be related to foster care placement (55, 124) and a high 
proportion of the children included in the present study lived in foster care. Earlier studies 
found an increased risk of RAD among children in foster care (55, 124). RAD can result 
from inadequate caregiving and develop when a child’s caregiving environment fails to 
address the child’s care needs (20, 48, 65). Thus, one can expect that a high rate of foster 
care placements is associated with inadequate caregiving in the biological home, or 
several placements in itself to be associated with RAD. In this study, no association was 
found between early placement into foster care (i.e. before 1 year of age) and symptoms 
of ASD.  
The majority of children included were placed outside their biological home and, 
in addition, were provided with supportive measures. The high rate of placement into 
foster care of children prenatally exposed to substances may be associated with factors 









Figure 4. The high rate of foster care placement may be associated with decreased 
parental caregiving abilities or the child’s possible increased care needs, or an interplay 
between these factors. 
 
Parental substance use is associated with multiple risk factors which can affect 
adequate child care (84). Inadequate caregiving in the biological home may lead to foster 
care placement of the child. Thus, a high rate of foster care placement could be 
independent of factors related to a child’s increased care needs. However, in addition, 
children may have increased care needs due to neurodevelopmental impairments, as well 
as withdrawal symptoms during the postnatal period. Neonates suffering from NAS have 
increased demands for appropriate support due to dysregulation, which can prove 
challenging to parents, irrespective of the parents’ caregiving abilities. Moreover, an 
increased risk of cognitive impairments and mental health problems may also affect the 
care demands during childhood and adolescence to be above what would be expected 
according to age and developmental stage. Thus, this challenging scenario involving 













increased care demands and decreased parental caregiving abilities can create a potential 
mismatch. 
 
5.5 Strengths and limitations 
5.5.1 Strengths 
An important strength of this study is the relatively large population of school-aged 
children prenatally exposed to substances. The participation rate of eligible children was 
high, with full completion of the comprehensive questionnaires in the vast majority of 
cases. 
Another strength is the use of standardized and validated screening tools to assess 
mental health, thus ensuring study reproducibility. The reference group included was 
taken from the large population of the Bergen Child Study and comprised children mainly 
from the same geographical area who were gender- and age-matched, thus enhancing the 
robustness of result comparability between the exposed and reference groups. Three 
controls were added for each case to improve the quality of the analyses (98). As age was 
considered to be an important matching factor in the present study, a relatively narrow 
matching criterion of  0.9 years was used, which allowed three eligible controls (3:1 
ratio). To achieve a 4:1 ratio between the controls and cases, the age-matching criterion 
would have had to be extended considerably to about  2 years. 
Moreover, the present study evaluated the long-term consequences of prenatal 
substance exposure on mental health and care situation in children aged from 6 to 14 
years. Most previous research which was conducted in children at preschool age, 
including studies examining the effects of NAS in the postnatal period (2, 6). Less is 
known, however, regarding the long-term consequences of prenatal substance exposure in 








Selection bias.  
The hospital-based design of this study meant that the study population likely included 
predominantly the most severely affected children, which thus represented only the “tip of 
the iceberg” of the population of children prenatally exposed to substances. Therefore, 
this selection bias has a major impact on the generalizability of the study findings (see 
also Section 5.3.2.2 below).  
 
Information bias 
Errors may be introduced both from the observer and the participants of the study. The 
following biases are relevant to this study. 
 
Observer bias: Children referred to the Department of Pediatrics all underwent clinical 
examination and psychological testing. However, the paediatricians and psychologists 
performing the examination and testing were not blinded to the children’s medical and 
history background. Hence, results from the clinical evaluation and neuropsychological 
testing could be biased. 
Recall bias: The present study was retrospective, and therefore subject to a risk of recall 
bias. In most cases, questionnaires were completed by foster parents, who, in some cases, 
provided second-hand information. 
 
Confounding factors  
The confounding factors presented below could explain the correlation or interaction 






Nicotine exposure: Nicotine exposure is a known risk factor affecting a child’s 
neurodevelopment (2, 6). However, data on maternal use of tobacco and nicotine during 
pregnancy were not available in this study. 
 
Birthweight and gestational age: Information about birthweight and gestational age (GA) 
was missing for 34% (n= 111) of the children in the exposed group. Therefore, these two 
parameters were not included as matching criteria for the reference group. Prematurity 
has been associated with an increased risk of mental health problems in childhood and 
adolescence (125). Of note, both low birthweight and prematurity are associated with, and 
could be a consequence of, prenatal substance exposure, in which case low birthweight 
and prematurity do not act as confounders (126). Other risk factors associated with 
prenatal substance exposure, such as poor maternal nutrition and increased risk of 
infection, may also influence a child’s birthweight and prematurity status (127). 
 
Socio-economic status: In the present study, no valid data on the SES were available. In 
some cases, foster parents provided information about their own SES, whereas in other 
cases, foster parents reported on what they knew about the SES of the biological parents. 
Therefore, it was not possible to control for the SES as a potential confounder in this 
study even though low SES has been associated with an increased risk of mental health 
problems (80).  
 
Parental mental health: The mental health of biological parents represents a potential 
confounding factor, given the link between genetic predisposition and several mental 
health disorders. However, information about parental mental health was not available 







Children prenatally exposed to alcohol and other substances were found to be at an 
increased risk of mental health problems in multiple domains, impacting their daily life 
functioning, when compared to a reference group. This increased risk may be related to 
prenatal substance exposure, or to other known and unknown risk factors, or most likely 
to an interaction between several factors. Prenatally substance-exposed children also had 
a high risk of foster care placement and were often provided with supportive measures, 
which could be a result of health problems influencing their needs for care and supportive 
measures. While this study was not able to demonstrate a direct causal relationship 
between prenatal drug exposure and the risk of mental health problems and the increased 
use of supportive measures, nevertheless, it highlights the key issues affecting children 
prenatally exposed to drugs—notably their increased risk of mental health problems, their 
propensity for out-of-home placement and the high rate of these children receiving 
supportive measures. Moreover, in this study, the children’s specific needs were not 
evaluated, and so the provision of supportive measures may not necessarily reflect the 
children’s actual needs for care and support. Further research is therefore needed in this 
area. Overall, this study would help provide a clear focus on the setting up and provision 
of optimized and appropriate health and care plans for this group of children, with 
minimal intervention delay. 
 
5.7 Clinical implications 
Children prenatally exposed to substances have an increased risk of mental health 
problems, which may impact on their daily life functioning. It is recommended that 
mental health assessment of children prenatally exposed to substances is conducted when 





be aware of the range of mental health symptoms associated with prenatal substance 
exposure, and supportive measures should be put in place accordingly. 
 
5.8 Future challenges and perspectives 
Due to stigmatization and the illegal nature of substance use during pregnancy, it is 
challenging to obtain an accurate picture of the extent of the problem of prenatal 
substance exposure. Therefore, further studies on a wider and more general population, 
i.e. not restricted to hospital-based settings, are warranted. Establishing a national register 
of all children with known prenatal substance exposure, including sampling of biomarkers 
of prenatal substance exposure, could contribute to improving the quality of data available 
for further studies. However, a high proportion of cases of prenatal substance exposure 
are likely to remain undetected. 
Routine monitoring for substance use in pregnant women is essential, and can be carried 
out within the current guidelines for antenatal care. These women are entitled to increased 
support and follow-up during pregnancy. In cases of known or suspected maternal 
substance use and dependency, there could be established routine urine and/or blood 
sampling from pregnant women and the newborn children.  
Finally, also of crucial importance is careful evaluation of the care and support 
needs of children prenatally exposed to substances, as well as the care and supportive 
measures that have been initiated in response to these needs. The ultimate aim is for these 
children’s needs to be adequately and appropriately met by optimized care and supportive 
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Alcohol, opiates, and most illicit drugs cross the placenta and 
can affect the fetus through direct effects on fetal development 
and indirectly through pharmacological effects on the pregnant 
mother.1–5 Prenatal substance exposure may result in neurode-
velopmental impairments through adverse effects on the fetal 
brain and can possible impact on subsequent mental health 
outcomes.2–4,6,7 Substance exposure in pregnancy represents a 
public health problem.1 Furthermore, it is difficult to estimate 
the prevalence due to inconsistent reporting from pregnant 
women and the illegal nature of illicit drug use.1,8,9
Prenatal exposure to alcohol
Alcohol is a well-known teratogenic substance, and alcohol 
exposure during pregnancy may result in fetal alcohol spec-
trum disorders (FASD).1,10,11 Fetal alcohol spectrum disor-
der comprises a spectrum of conditions presenting with 
mild to severe neurodevelopmental consequences such as 
cognitive impairment and an increased risk of specific learn-
ing disabilities, attention-deficit/hyperactivity disorder 
(ADHD), and anxiety and mood disorders.1,10–12 Other 
important sequelae associated with prenatal alcohol exposure 
include an increased risk of miscarriage, preterm birth, pre-
natal and postnatal growth restriction, and sudden death 
infant syndrome, as well as effects on various organ systems 
such as the cardiovascular, musculoskeletal, renal, ocular, and 
auditory systems.1,12 The impact of maternal alcohol use on 
fetal development depends on a variety of factors, including 
the timing and level of alcohol exposure and genetic back-
ground.13 Recent research exploring the epigenetic mecha-
nisms involved in fetal exposure to alcohol suggests a link 
between the genetic background, environmental factors, and 
neurodevelopmental outcomes.13
Prenatal exposure to substances other than alcohol
Prenatal substance exposure also includes exposure to opi-
oids, amphetamine, methamphetamine, cocaine, and canna-
bis and the illegal use of benzodiazepines. Exposure to these 
substances is associated with low birthweight, preterm births, 
and, particularly in the case of opioids, neonatal abstinence 
syndrome (NAS).1,14,15 Systematic reviews of children 
exposed to substances other than alcohol have reported an 
increased risk of cognitive and behavioral impairments later 
in preschool age.3,6 Furthermore, some longitudinal studies 
found that cognitive difficulties in preschool-aged children 
persisted into school and adolescence age, and a recent study 
reported effects in children of exposure to substances other 
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than alcohol on cognition increasing over time, compared 
with nonexposure.6,7,16,17 Less is known about the mental 
health outcomes of prenatal exposure to other substances in 
school-aged children.3
Genetics and environmental factors affecting 
mental health
Children prenatally exposed to substances are influenced by 
several risk factors, including biological, genetic, environ-
mental, and socioeconomic factors that are associated with 
mental health outcomes.6,18–21 Parental substance use 
increases the risk of poverty, family stress, low level of paren-
tal education, poor prenatal care, and family instability, as 
well as being a risk factor for placement of children into fos-
ter care.22,23 Exposure to inadequate caregiving conditions 
earlier in life may affect the mental health later in life, and 
optimizing care conditions is likely to have a positive effect 
on mental health outcomes.23,24 For youth placed in foster 
care in western countries, the prevalence of mental disorders 
has been estimated to be higher than that for the general 
population.23,25
Aim of the study
The aim of this hospital-based follow-up study was to assess 
mental health in school-aged children prenatally exposed to 
alcohol and other substances, in comparison with a reference 
group as control. We hypothesized that prenatal exposure to 
substances would result in higher mean scores on the Strength 
and Difficulties Questionnaire (SDQ) in exposed children, 
compared with controls. Furthermore, given the known terato-
genic effects of alcohol, we expected higher mean SDQ scores 
in children mainly exposed to alcohol, compared with those 
mainly exposed to other substances.
Methods
Participants
The study included a hospital-based population of children 
referred to the pediatric department at Haukeland University 
Hospital in Bergen, Norway, between January 1997 and 
December 2012. Referral criteria included the presence of 
developmental impairments and a concomitant past medical 
history of prenatal alcohol or other substance exposure. 
Referrals to the pediatric department were from healthcare 
providers, social workers, and physicians in primary com-
munity care units and pediatric and child psychiatric units.
A follow-up study on mental health status was conducted 
at school age. At this point, in the study, 128 children aged 
between 6 and 14 years were invited to participate; of whom, 
111 gave informed written consent (87%). Of the 111 chil-
dren, 105 (95%) had their caregivers complete the SDQ 
questionnaire.
The reference group
The reference group consisted of children participating in the 
Bergen Child Study (BCS), which is a longitudinal popula-
tion-based study. There were no exclusion criteria,26 and all 
children attending grades 2 to 4 at 79 schools in a geographi-
cally delineated area in the academic years of 2002 and 2003 
were invited to participate in the study (n = 9430). Parent SDQ 
questionnaires were completed for about two-thirds of the par-
ticipating children (n = 6297).26 Of the participating children 
in BCS, about 2 out of 3 lived in a family categorized as having 
good or very good family economy, and about 50% of the 
mothers and fathers had higher education.27 More details 
about the reference group are presented in the papers by 
Heiervang et  al,26 Boe et  al,27 and Stormark et  al.28 In this 
study, participants from the first 2 waves were included. The 
first wave of the BCS, conducted in autumn 2002, comprised a 
target population of 9430 primary school children aged 7 to 
9 years, and informed consent to participate was received from 
7007 (74%) parents prior to study inclusion. The second wave 
was conducted 4 years later during spring 2006, comprising 
5683 children aged 11 to 13 years (60% of the original target 
population). For every participating child in the hospital-based 
group of children prenatally exposed to substances, 3 children 
from the BCS population, who were sex and age matched 
(±0.9 years), were randomly selected into the reference group. 
Three controls were included for each case to improve the 
robustness of the analyses.29 As we considered age to be an 
important matching factor in this study, we used a relatively 
narrow matching criterion of ±0.9 years, which hence allows 3 
eligible controls from the BCS. We considered that a 3:1 ratio 
worked best with the available data, as to achieve a 4:1 ratio 
between the controls and cases would require the age matching 
criterion to be extended to about ±2 years.
Ethics
The study was approved by the Regional Committee for 
Medical Research Ethics in Norway. For children prenatally 
exposed to substances, informed written consent was obtained 
from all participating caregivers: biological parents for children 
living in their biological home and foster parents for children 
living in foster care. For children in foster care, the social welfare 
office legally responsible for the participating child also gave 
written consent. Children 12 years and older, gave their inde-
pendent consent to participate in the study. For the reference 
group, children’s caregivers gave informed written consent.
Care situation
The following data were collected from medical records and 
questionnaires completed by the caregivers: the present care 
situation and age at time of placement in cases where the child 
was placed in a foster home before and after 1 year of age.
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Participant categorization according to prenatal 
substance exposure
Children with confirmed prenatal exposure to substances, 
including alcohol, illicit drugs, illegal use of prescription drugs, 
and opioids used in opioid management treatment (OMT) 
programs, were included in the study. History of exposure was 
confirmed by information obtained from the mothers and 
obstetric or pediatric records, including data from referring 
units and medical reports of neonatal withdrawal symptoms 
after birth. Data were systematically recorded based on the 
mother’s main drug of use during pregnancy, and the children 
were categorized into 2 groups: (1) prenatal exposure to alcohol 
(FASD group) and (2) prenatal exposure to other substances. 
No valid information was available on doses of substance used 
in pregnancy, including the number of units of alcohol con-
sumed or the exact timing of exposure during pregnancy.
If there was evidence from the data collected that a child had 
been exposed to both alcohol and other substances, the child 
was placed in the FASD group if alcohol was the main drug of 
use by the mother and if there were reported regular, or more 
often than occasional, episodes of alcohol use during pregnancy. 
Also, if a child met the criteria for FASD, he or she was auto-
matically placed in the FASD group, which meant that no chil-
dren in the other substances group met the FASD criteria.
Fetal alcohol spectrum disorders. The FASD group included 
cases of both fetal alcohol syndrome (FAS) and FASD. The 
diagnosis of FAS or FASD was given after evaluation of the 
medical history and clinical examination by a pediatrician with 
relevant specialized training and neuropsychological testing. 
Differential diagnoses were considered in all cases, and pedia-
tricians specially trained in the field, including pediatric endo-
crinologists, were consulted in cases of uncertain diagnosis. 
Fetal alcohol syndrome was diagnosed if a child with confirmed 
prenatal alcohol exposure met all of the following Centers for 
Disease Control and Prevention (CDC) criteria:10 (1) presence 
of facial dysmorphic features, (2) growth restriction, and (3) 
central nervous system (CNS) impairment. Children who did 
not fulfill all 3 FAS criteria were diagnosed with FASD.
Central nervous system impairment was defined as the pres-
ence of learning disabilities (defined as an IQ below 85) or hav-
ing ADHD. Intellectual level was determined using either the 
Wechsler Preschool and Primary Scale of Intelligence (WPPSI) 
test or the Wechsler Intelligence Scale for Children-Revised 
(WISC-R) test. An IQ below 70 was defined as intellectual dis-
ability and an IQ of 70 to 84 as low IQ. Attention-deficit/
hyperactivity disorder was diagnosed by a pediatrician and a 
child psychiatrist according to the International Classification 
of Diseases, Tenth Revision criteria.
Prenatal exposure to other substances. This group included chil-
dren exposed to street drugs and polydrug use, as well as those 
exposed to opioids as part of the national OMT (the latter 
including 9 children). The most common “other substances” 
reported in this group were opiates and polydrug use. Children 
in this group either had a medical history of prenatal drug 
exposure to one or more drugs or were diagnosed with NAS 
after birth. None of the children in this group met the criteria 
for FASD. Although nondocumented (ie, unknown) use of 
alcohol could not be totally excluded, but the mother’s main 
drug of use included substances other than alcohol. Any 
involvement of the mother in the national OMT during preg-
nancy was also recorded.
Mental health
The SDQ is a behavioral screening questionnaire for 4 to 
17-year-old children.30–32
In this study, the SDQ questionnaire was completed by the 
children’s caregivers. It consists of 25 items describing positive 
and negative attributes of the children, and it is divided into 5 
subscales: (1) emotional problems, (2) hyperactivity problems, 
(3) conduct problems, (4) peer problems, and (5) prosocial 
behavior. For subscales other than the prosocial behavior sub-
scale, a higher score represents more mental health problems. A 
total difficulties score (TDS) was computed by adding the first 
4 subscale scores. Each item is scored on a 3-point scale, ie, “not 
true,” “somewhat true,” and “certainly true,” with total subscale 
scores ranging from 0 to 10 and TDS from 0 to 40.30
The impact supplement of the SDQ is activated by a posi-
tive response to one screening item, indicating difficulties in 
areas of emotions, concentration, behavior, or social skills. The 
impact supplement of the SDQ examines overall distress and 
social impairment at home, with friends, at school, and with 
leisure activities. Each item is rated on a 4-point scale, rating 
difficulties as “not at all,” “only a little,” “quite a lot,” and “a great 
deal.” This is summed up to a total impact score with a maxi-
mum score of 10. If the child is not considered to have a prob-
lem, the impact score is scored as 0.30
The SDQ is widely used in groups of at-risk children such 
as children with chronic illness, those with intellectual disabili-
ties, and those prenatally exposed to substances.7,30,33–35 Its use 
as a screening instrument for mental health disorders in foster 
children has been previously validated.36
Statistical analyses
First, independent t tests were used to compare mean scores 
on symptom subscales, TDS, and total impact scores between 
the group of children prenatally exposed to alcohol or other 
substances and the reference group. Cohen d was used to 
quantify the differences between the groups, and standard 
interpretation was used (0.20 = small, 0.50 = moderate, and 
0.80 = large). Second, the FASD group and the group of chil-
dren exposed to substances other than alcohol were each 
compared with the reference group, and third, the FASD 
group and the group of children exposed to other substances 
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were compared with each other. The characteristics of the 
2 groups (ie, FASD group and group exposed to other 
substances) were analyzed using a χ2 test for gender and care 
situation. Finally, a regression analysis for the substance was 
performed, with the TDS as the dependent variable and 
gender, age, IQ, drug group, and care situation as independent 
variables. Information about care situation and IQ was not 
available for the reference group. We also used the Mann-
Whitney U test to assess if this test affected the statistical 
significance when comparing the groups. This test is suitable 
for small-sized samples and where the distribution is not 
normal. IBM SPSS version 22 for Windows was used for all 
analyses. The significance level was set at P ⩽ .05.
Results
Participants
The mean age of substance-exposed children was 10.6 years 
and comparable with the reference group (Table 1). Of the 105 
children exposed to substances, 48 had FASD and 57 were 
exposed to substances other than alcohol.
Of the 48 children in the FASD group, 20 (42%) met all 3 
CDC criteria and were given a diagnosis of FAS. The remain-
ing 28 children in the FASD group had some of the dysmor-
phic facial features associated with FAS but did not fulfill all 
the CDC criteria for dysmorphic facial features, although they 
all met the other CDC criteria for growth restriction and CNS 
impairment.
Of the 57 children in the group exposed to substances other 
than alcohol, 41 (72%) had symptoms of NAS, 5 were reported 
as not having symptoms of NAS, whereas no valid information 
about the NAS status was available for the remaining 11 
children.
Overall, 3 children were living with their biological families, 
12 were adopted, and 90 were in foster care. In all, 11 children 
were placed in foster care at birth, a further 18 within the first 
year, and 61 after 1 year of age. There were no significant gender 
or age differences between the 2 groups. Compared with the 
FASD group, the mean IQ was significantly higher (P = .001) in 
the group exposed to substances other than alcohol. The mean 
IQ of the 20 children diagnosed with FAS was 75 (SD: 17.6, 
95% CI = 67-83), with a median IQ of 70, whereas the mean IQ 
for the remaining 28 children in the FASD group was 85 (SD: 
20.9, 95% CI = 76-92), with a median IQ of 85. There were no 
statistically significant differences (P = .13) between the groups.
Mental health in the substance-exposed group 
compared with the reference group
Mean scores for the SDQ subscales, TDS, and total impact 
scores for the substance-exposed group, compared with the ref-
erence group, are presented in Table 2. There were statistically 
significant differences in all 5 SDQ subscales, TDS, and total 
impact scores between the group of alcohol-exposed and sub-
stance-exposed children and the reference group. A large effect 
size was obtained for all subscales and TDS (d ⩾ 0.80), with 
the greatest difference noted for the hyperactivity subscale 
between the group prenatally exposed to substances and the 
reference group (d = 2.29). After accounting for multiple testing 
and using the Bonferroni correction (critical P = .05/number of 
tests), we found that the group differences remained statisti-
cally significant for all tests. Use of the Mann-Whitney U test 
to compare SDQ scores between the groups did not change the 
statistical significance of the results.
When comparing the FASD group and the group of chil-
dren exposed to other substances, no statistically significant 
differences were found in any of the 5 SDQ subscale scores, 
TDS, or total impact scores (Table 3).
Within the group exposed to other substances, 9 children 
were born to mothers in the national OMT. There were no dif-
ferences in mean scores on any of the SDQ subscales between 
these children and the other 48 children in the group.














Mean age in years (SD) 10.5 (2.0) 10.6 (2.2) 10.8 (2.2) 10.3 (2.2)  
gender (boys) (%) 188 (60) 63 (60) 27 (56) 36 (63)  
COMPARINg SUBgROUPS OF CHILDREN WITH FASD AND CHILDREN ExPOSED TO SUBSTANCES 
OTHER THAN ALCOHOL
MD 95% CI P
Mean IQ (SD) 88 (21) 80 (20) 94 (20) 13 (MD) 5.1–21 .001
In foster care (%) 90 (86) 36/48 (75) 54/57 (95) 2.0 (OR) 0.04–0.63 .004
In foster care ⩽1 year (%) 29/90 (32) 9/36 (25) 20/54 (37) 1.4 (OR) 0.7–2.8 .200
Abbreviations: CI, confidence interval; FASD, fetal alcohol spectrum disorder; MD, mean difference; OR, odds ratio.
aFetal alcohol spectrum disorders.
bOpioids, amphetamine, methamphetamine, cocaine, cannabis, and benzodiazepines.
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Mental health and care situation in the substance-
exposed group
Among the 90 children living in foster care, there were no sta-
tistically significant differences in the mean TDS between 
those taken in foster care at birth, those placed before 1 year of 
age, and those placed after 1 year of age (mean TDS: 17, 18, 
and 20, respectively; P = .30).
In a regression analysis with the TDS as the dependent vari-
able and referral age, gender, IQ, substance group, and care 
situation as independent variables, only low IQ was a signifi-
cant factor explaining a variance of 6% (adjusted R2 = 0.06; 95% 
CI = 16-32; P = .01).
Discussion
In this hospital-based study of school-aged children prena-
tally exposed to alcohol and other substances, we found that 
the exposed children were at increased risk of mental health 
problems, compared with the reference group. In addition, 
mental health problems had a more marked impact on daily 
life functioning in the exposed group, in comparison with the 
reference group.
In this study, most of the prenatally exposed children had 
mental health problems affecting their daily life functioning; 
both the FASD group and the group of children exposed to 
other substances had high SDQ scores. This indicated an 
increased risk of mental health problems, compared with the 
reference group, with no statistically significant differences 
between the 2 study groups. The increased risk of mental 
health problems is in agreement with other studies of prena-
tally exposed children.4,6,7,20,37
The greatest mean difference between the exposed group 
and the reference group was obtained in the hyperactivity 
SDQ subscale, which is consistent with previous studies that 
reported high scores of hyperactivity symptoms both in the 
FASD group as well as in the group of children exposed 
to substances other than alcohol.1,6,37–39 When comparing 
the exposed group with the reference group, the mean differ-
ence in the hyperactivity subscale could only partly explain 
the mean difference in the TDS between the groups, indicat-
ing that children exposed to substances present with a wider 
range of mental problems. Irner et  al7 who, also using the 
SDQ, reported a higher proportion of hyperactivity in a 
group of prenatally exposed children, compared with British 
norms.
Children may be genetically predisposed to ADHD, and a 
recent review highlighted that ADHD may develop as a result 
of a complex process involving both genetic and nongenetic 
factors.40 Studies of adults having substance use disorder have 
found a higher rate of ADHD symptoms, with ADHD itself 
as an independent risk factor for substance abuse.41 Other pre-
vious studies have also described an association between mater-
nal mental health and behavioral problems in their children.42,43 
However, we were not able to investigate this issue in our study 
because most of the children were not living with their biologi-
cal parents.
The increased risk of mental health problems in children 
prenatally exposed to alcohol and other substances may thus be 
due to factors other than the direct or indirect effects of alcohol 
and other substances on the developing brain. This is sup-
ported by findings from previous studies showing that factors 
such as children’s socioeconomic status, caregiving environ-
ment, and learning disabilities influence mental health out-
comes.18,21,23,27 In this study, we found an association between 
cognitive impairments and poorer mental health status, in line 
with previous reports.18 Furthermore, numerous studies have 
found that a high proportion of children prenatally exposed to 
alcohol and other substances were placed in foster homes and 
that changes in care environment could affect the mental 
Table 2. Mental health problems based on Strengths and Difficulties Questionnaire scores in a hospital-based population of school-aged children 







MD 95% CI P COHEN db (CI)
Emotional problems (SD) 4.0 (2.5) 1.3 (1.7) −2.7 −3.1 to −2.3 <.01 1.93 (0.92–1.59)
Conduct problems (SD) 3.6 (2.3) 1.0 (1.3) −2.6 −3.0 to −2.3 <.01 1.61 (1.18–1.76)
Hyperactivity problems (SD) 7.6 (2.3) 2.5 (2.2) −5.0 −5.5 to −4.5 <.01 2.29 (1.85–2.54)
Peer problems (SD) 3.6 (2.5) 1.1 (1.6) −2.5 −3.0 to 2.1 <.01 1.34 (0.86–1.52)
Prosocial behavior (SD) 6.4 (2.4) 8.5 (1.5) 2.0 −1.6 to −2.4 <.01 1.19 (1.02–1.65)
Total difficulties (SD) 18.9 (6.7) 5.9 (5.0) −12.9 −14.2 to −11.7 <.01 2.37 (1.09–2.93)
Impact scorec (n = 87) (SD) 4.2 (3.0) 0.4 (1.4) −3.8 −4.3 to −3.4 <.01 1.97 (1.40–2.13)
Abbreviations: CI, confidence interval; FASD, fetal alcohol spectrum disorder; MD, mean difference.
aClinical population of children exposed to alcohol and other substances.
bCohen d: 0.20 = small, 0.50 = moderate, 0.80 = large.
cn for FASD = 45; n for other substances = 42.
































































































































































































































































































































































































































































































































































































































































































































































































































































































































health status.44–46 In our study population, an increased risk of 
mental health problems was found in school-aged children, 
with no statistically significant differences between children 
placed in foster care before and those placed after 1 year of age. 
It has been suggested that prenatally drug-exposed children are 
biologically vulnerable to the effects of poor caretaking and a 
poor caregiving environment and that optimizing care condi-
tions may thus improve developmental outcome.19,47–49
In this study, there were no differences in mental health out-
comes between children prenatally exposed to alcohol and 
those exposed to substances other than alcohol. This suggests 
that exposure to other substances may also affect neurodevel-
opment and mental health, as also suggested by earlier stud-
ies.1,3,4,7,50 In addition, mental health problems impaired the 
children’s daily life functioning, irrespective of the main type of 
substance exposure and environmental factors, to such an 
extent that it calls for special focus for this group of children. 
These findings indicate a need for mental health assessment of 
children prenatally exposed to alcohol and other substances to 
provide early intervention if necessary.
Our study results should be interpreted with caution due to 
some limitations. One limitation was our inability to verify the 
accuracy of the types of substances used and to which the fetus 
was exposed, as reported by the children’s mothers. This 
underlines the potential risk of underestimating the actual 
prenatal exposure to specific substances. Previous studies have 
reported many mothers in OMT with an illicit polydrug use 
while on the opioid maintenance program, highlighting the 
complexity of accurately measuring actual drug exposure.51,52 
In this study, it was not possible to ascertain that mothers to 
children prenatally exposed to other substances had not con-
sumed any alcohol, in addition to other substances, during 
their pregnancy. Thus, we relied on obstetric and pediatric 
records, as well as reports from mothers, and in cases showing 
any confirmation or evidence of a greater number of single 
episodes of alcohol exposure, the children were categorized in 
the FASD group. None of the children in the group of prena-
tal exposure to other substances met the criteria for FASD. 
Our initial hypothesis was that given the known teratogenic 
effects of alcohol, alcohol-exposed children had a higher risk 
of mental health problems, compared with children exposed to 
substances other than alcohol. However, we found this was not 
the case in this study and suggest that children with a positive 
medical record of prenatal substance exposure have an 
increased risk of mental health problems, irrespective of the 
mother’s main substance of use.
Another limitation is that although nicotine exposure is 
also a known risk factor affecting a child’s neurodevelop-
ment,1,6 data on maternal use of tobacco and nicotine were not 
available in our study. A further limitation is that the study has 
a hospital-based study design, which likely resulted in selec-
tion bias of participants meaning that our hospital-based study 
population represented mainly the most severely affected 
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children. This has a major impact on the generalizability of 
our study findings, and hence, the results should be interpreted 
with caution. Therefore, further studies on a wider and more 
general population, ie, not restricted to hospital-based set-
tings, are warranted.
It is possible that the statistical models presented in 
this study could raise some methodological concerns using of 
IQ scores as a variable when exploring neurodevelopmental 
outcomes.53 For our purpose, we found it appropriate to 
include the IQ scores when comparing the subgroups of 
exposed children because the scores are a measure of global 
cognitive function according to the diagnostic criteria of 
FASD.10
We consider the SDQ suitable for our study to identify the 
risk of mental health problems in prenatally exposed children, 
given that most of these children were taken into foster care. 
Indeed, a study examining the properties of the SDQ in chil-
dren placed in foster care in Norway supports the use of the 
SDQ when screening children in foster care for mental health 
problems, compared with the diagnostic interview of 
Developmental and Well-Being Assessment.36
Conclusions
In this study of a hospital-based population of school-aged 
children prenatally exposed to alcohol or other substances, we 
found that these children were at increased risk of mental 
health problems affecting their daily life functioning, with no 
difference between whether the mother’s main drug of use dur-
ing pregnancy was alcohol or other substances.
Clinical implications
Given the increased risk of mental health problems, we recom-
mend the performance of mental health assessment for this 
group of children when referring to healthcare providers. We 
believe this approach to be important in establishing an opti-
mized healthcare plan, with minimal intervention delay, for 
this group of children, and more research to evaluate the treat-
ment measures on mental health outcomes in this group is 
needed.
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Prenatal exposure to opiates and illicit drugs may influence 
neurodevelopment in children,1 including mental health.2–6 
Earlier studies of prenatal substance exposure have reported 
neurodevelopmental impairments in school-aged children 
and adolescents.7–11 However, it may be difficult to distin-
guish between long-term outcomes of prenatal substance 
exposure and outcomes of other influencing factors on a 
child’s development.3,12,13 Previous research suggested that in 
addition to prenatal substance exposure, genetic and epige-
netic factors,14 gender,15,16 cognitive functioning,17,18 and 
environmental conditions, including the quality of caregiv-
ing environment in early childhood,10,11,19–23 are all associ-
ated with mental health outcomes in children and adolescents. 
Parental substance abuse is associated with an increased risk 
for foster care, heightening the risk for placement in foster 
care for the group of prenatal substance-exposed children.24,25 
Furthermore, it has been suggested that optimization of car-
egiving environments, including placement in foster care, 
may improve developmental outcomes in children prenatally 
exposed to substances.9,11,20 Regardless of the different fac-
tors affecting children’s neurodevelopment, it is important to 
examine the mental health status and describe potential 
challenges for the group of prenatally substance-exposed 
children.26
It is difficult to obtain a true estimate of the prevalence of 
prenatal substance exposure in children, due to stigmatization 
and the illegal nature of illicit drug use.2,27 However, it is clear 
that the incidence has increased over the past decade in the 
United States and Western European countries, with an 
increasing number of neonates diagnosed with withdrawal 
symptoms.28 Children prenatally exposed to substances, in 
particular opiates, are at risk for withdrawal symptoms and 
neonatal abstinence syndrome (NAS).28,29 Neonatal absti-
nence syndrome is a complex disorder affecting various 
organs, and clinical manifestations range from mild, such as 
irritability and mild tremors, to severe such as seizures, exces-
sive weight loss, and fever.28,29 Neonatal abstinence syndrome 
occurs in 55% to 94% of children prenatally exposed to 
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opioids.28–30 A follow-up study of children with NAS also 
found an increased risk for rehospitalization due to maltreat-
ment, trauma, mental health problems, and behavioral disor-
ders when compared with controls.5
Overall, substance-exposed children seem to be vulnerable, 
having several risk factors for developing mental health prob-
lems. Interestingly, some studies have suggested that cumula-
tive risk factors, including prenatal substance exposure and the 
caregiving environment, may exert a greater impact on devel-
opment than prenatal substance exposure itself.31,32
A recent review of alcohol-exposed children found the rate 
of attention deficit/hyperactivity disorder (ADHD) to be 15 
times higher, and autism spectrum disorders (ASD) twice 
higher, compared with the general population.33 Moreover, it is 
well established that children prenatally exposed to substances 
other than alcohol have an increased risk for hyperactivity.2,3,8 
A recent study, using the Strengths and Difficulties 
Questionnaire (SDQ), reported that children exposed to alco-
hol and other substances had a higher risk for mental health 
problems, compared with controls, including hyperactivity 
problems as well as other domains of mental health problems.26 
Based on the above, it is of interest to examine in more details 
specific mental health outcomes in children exposed to sub-
stances during pregnancy.
The aims of this study are as follows: (1) to evaluate symp-
toms of ADHD and ASD in children prenatally exposed to 
substances other than alcohol, compared with a reference group 
and (2) to determine relevant predictors of mental health out-
comes in substance-exposed children. We hypothesized that 
children prenatally exposed to substances would display a 
higher number of symptoms of ADHD and ASD, compared 
with the reference group.
Methods
Study participants
This study included children aged 6 to 14 years, prenatally 
exposed to opiates and a number of illicit drugs, who were 
referred to the Pediatric Department at Haukeland University 
Hospital in Bergen, Norway, from January 1997 to December 
2012. The study population is hospital-based, including chil-
dren referred to the pediatric department at the hospital, and 
referral criteria included symptoms of developmental impair-
ment in the presence of a medical history of prenatal exposure 
to drugs. Some of the children were hospitalized after birth due 
to abstinence symptoms; others were referred later in child-
hood when suspecting developmental impairments.
Referrals were by health care providers, social workers, and 
physicians in primary health care, as well as in pediatric units 
and child psychiatric units. Of a total number of 128 children 
referred, informed written concent was provided for 87% (n = 111). 
Children mainly exposed to alcohol (n = 50) were excluded from 
the study. Of 61 children exposed to substances other than 
alcohol, 57 (93%) completed relevant questionnaires assessing 
the mental health status and care situation (Table 1). The ques-
tionnaires were distributed when the child was included in the 
study, earliest at 6 years of age. The mean age of the child at 
completion of the questionnaires is given in Table 1, and the 
current caretakers were the informants.
The reference group
This group consisted of children participating in the longitudi-
nal population-based Bergen Child Study (BCS). All children 
attending grades 2 to 4 at 79 schools in a geographically 
restricted area during the academic years of 2002/2003 were 
invited to participate in the study (N = 9430); there were no 
exclusion criteria.34 Parent questionnaires were completed for 
about two-thirds of the participating children (N = 6297).34 Of 
the participating children in the BCS, about 2 out of 3 lived in 
a family categorized as with good or very good family economy, 
and about 50% of the mothers and fathers had higher 
education.35 More details about the reference group are pre-
sented in the papers by Heiervang et  al,34 Bøe et  al,35 and 
Stormark et al.36 This study included participants from the first 
two waves of the BCS. The first wave, conducted in autumn 
2002, was composed of a target population of 9430 primary 
schoolchildren aged 7 to 9 years, and informed consent to 
Table 1. Characteristics of a hospital-based population of school-aged children prenatally exposed to substances, compared with a reference group.
ExPOSED gROUP (N = 57) REFERENCE gROUP (N = 171)
Mean age in years (SD) 10.4 (2.2) 10.3 (2.0)
gender (boys), N (%) 37 (65) 111 (65)
Mean IQ (SD) 93.5 (20.4)  
Neonatal abstinence symptoms, N (%) 41 (72)  
NAS, N (%) 18/41 (44)  
Out of biological home at age ≤1 yeara, N (%) 22 (39)  
Abbreviations: IQ, intelligence quotient; NAS, neonatal abstinence syndrome; SD, standard deviation.
aAdopted or in foster care (n = 56) at age ≤1 year.
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participate was obtained from 7007 (74%) parents prior to 
study inclusion. The second wave was conducted 4 years later 
during spring 2006, comprising 5683 children aged 11 to 13 
years (60% of the original target population).
For every participating child in the hospital-based group of 
children prenatally exposed to substances included in this 
study, 3 children from the BCS population, who were sex- and 
age-matched (±0.9 years), were randomly selected into the ref-
erence group. Three controls were added for each case to 
improve the quality of the analyses.37 As we considered age to 
be an important matching factor in this study, we used a rela-
tively narrow matching criterion of ±0.9 years, which therefore 
allowed 3 eligible controls from the BCS. As we would have to 
considerably expand the age-matching criterion (to about ±2 
years) to achieve a 4:1 ratio between controls and cases, we con-
sidered a 3:1 ratio to best use the available data.
Exposure to substances
Children with confirmed prenatal exposure to substances were 
included in the study. Substance exposure was defined as pre-
natal exposure to opiates and a number of illicit drugs and illicit 
use of prescribed drugs with psychoactive or sedative effects. In 
addition, children were included in the study if they were 
exposed to opioids as part of the national opioid maintenance 
treatment program (OMT) and/or they presented with neona-
tal withdrawal symptoms or NAS after birth. Prenatal exposure 
was confirmed by information obtained from mothers and 
obstetric or pediatric records, including details from referring 
units and reports of neonatal withdrawal symptoms.
In cases involving exposure to both alcohol and other sub-
stances, the mother’s main substance of use was taken into 
account to determine a child’s eligibility for inclusion in the 
study. In cases involving a greater number of single episodes 
of alcohol exposure, or if a child met the criteria of fetal alco-
hol spectrum disorders (FASD), the child was excluded from 
the study.
Withdrawal symptoms and NAS
The presence of withdrawal symptoms in children was assessed 
for and recorded, and abstinence symptoms were scored using 
a modified version of the Finnegan abstinence score.29 
Abstinence scores of 8 or above were classified as NAS.
Care situation
Based on the medical records and questionnaires completed by 
the children’s respective caregivers, data on the current care 
situation were obtained, as well as age at first placement outside 
of the biological home (before or after 1 year of age). Early 
placement in an adopted home or foster care was defined as 
placement before 1 year of age.
Cognitive functioning
Cognitive functioning in exposed children was evaluated using 
either the Wechsler Preschool and Primary Scale of Intelligence 
(WPPSI) test38 or the Wechsler Intelligence Scale for 
Children–Revised (WISC-R).39
Mental health
Mental health assessment was based on 2 different question-
naires—the Swanson, Nolan, and Pelham Questionnaire, revi-
sion IV (SNAP-IV) and the Autism Spectrum Screening 
Questionnaire (ASSQ), both comprising items scored on a 
3-point scale (0-2). The questionnaires were completed by the 
current caregivers.
The Swanson, Nolan, and Pelham Questionnaire, revision 
IV. The SNAP-IV is a screening tool for ADHD.40 It con-
tains 9 items on inattention and 9 items on hyperactivity/
impulsivity, which correspond to the Diagnostic and Statistical 
Manual of Mental Disorders (Fourth Edition; DSM-IV) crite-
ria for ADHD.41 Scores ranged from 0 to 18 for each scale. 
The SNAP Combined variables consisted of the sum of all 18 
items. Reliability of SNAP-IV as a screening tool has been 
reported as good.
The Autism Spectrum Screening Questionnaire. The ASSQ con-
sists of 27 items covering symptoms of ASD, ie, social interac-
tion and communication, motor clumsiness, tics, and restricted 
and repetitive behavior.43–45 In this study, one of the items 
(item 9 related to involuntary sounds and words) was inadvert-
ently omitted for the reference group and therefore not 
included.44 Scores ranged from 0 to 52.
For further description of symptoms reported in ASSQ, the 
26 items were computed into 3 subscales, as suggested in 
Ryland et al46: (1) social difficulties, including items related to 
difficulties with friendship, prosocial behavior, and social com-
munication; (2) motor/tics/obsessive–compulsive disorder 
(OCD), including items related to repetitive, stereotype behav-
ior, and autism-associated symptoms such as motor difficulties 
and tics; and (3) autistic style, including items related to char-
acteristics often seen in high-functioning individuals with 
ASD. The specific items included in each subscale are as fol-
lows: (1) social difficulties: lives in own world, no social fit in 
language, lacks empathy, naive remarks, deviant style of gaze, 
fails to make friends, sociable on own terms only, lacks best 
friend, lacks common sense, poor at games and own rules, and 
bullied by other children; (2) motor/tics/OCD: different voice/
speech, clumsy, involuntary movements, compulsory repetition, 
insists on no change, idiosyncratic attachment, unusual facial 
expression, and unusual posture; and (3) autistic style: old-
fashioned or precocious, eccentric professor, accumulates facts, 
literal understanding, robot-like language, idiosyncratic words, 
and uneven abilities.46
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Statistical analyses
Descriptive analyses were used to describe the sample (mean, 
standard deviation, and frequency). Group differences were 
analyzed using the t-test. Levene’s test was used to test homo-
geneity of variances. If variances were found to be statistically 
unequal, the t-test not assuming equal variances was used.47 
Effect sizes were estimated by Cohen’s d. IBM SPSS version 
24 was used for all analyses.48
Regarding the use of ASSQ, it has been recommended a cut-
off score of 17 or more is optimal in screening for ASD.45 We 
therefore used a cutoff value of ≥17 as high score in our analyses 
comparing child placement outside of the biological home 
before and after 1 year of age. Due to skewness in outcome vari-
ables in the reference group, the program Mplus version 7.4 was 
used with the maximum likelihood robust (MLR) estimator 
and corrected standard errors for sensitivity analyses.49,50 This 
analysis strategy does not assume equal variances when compar-
ing the groups. Spearman correlation was used when analyzing 
the relationship between SNAP-IV and ASSQ scores.
In the group of children prenatally exposed to substances, 
multiple regression analysis was used to predict the outcome 
variables SNAP Combined, SNAP Inattention, and SNAP 
Hyperactivity/impulsivity and ASSQ Total score, ASSQ Social 
difficulties, ASSQ Motor/tics/OCD, and ASSQ Autistic style. 
Predictors were age, gender, intelligence quotient (IQ), NAS, 
and child placement outside of the biological home before or 
after 1 year of age based on earlier studies of prenatal substance 
exposure and mental health in children.5,10,11,14–18,20,23
For 21 children in the exposed group, one or more responses 
on the ASSQ were missing. For missing data, the variables 
were replaced with imputed data based on the expectation–
maximization method and ASSQ total scores computed.51
Ethics
The study was approved by the Regional Committee for 
Medical Research Ethics in Norway (approval number 
2010/3301). For children prenatally exposed to substances, 
informed written consent was obtained from all participating 
caregivers. These included biological parents if the child was 
living in the biological home, adoptive parents, or foster par-
ents if relevant for the care situation. For children in foster care, 
the social welfare office legally responsible for the participating 
child also gave written consent. In addition to the caregivers 
and social welfare office, children 12 years and older gave their 
independent consent to participate in the study. For the refer-
ence group, the caregivers gave informed written consent.
Results
Study participants
The characteristics of the hospital-based population of chil-
dren prenatally exposed to substances and the reference group 
are presented in Table 1. Almost 2 in 3 participants were boys, 
and the mean IQ was within the normal range for the entire 
study sample. In the exposed group, all, except 1 child, lived in 
foster care (n = 54) or with adopted parents (n = 2), and of the 
children adopted or in foster care (n = 56), more than 1 in 3 
were placed outside of their biological home before the age of 
1 year. The mean age at follow-up was approximately 10 years, 
with age normally distributed and approximately 95% of the 
sample in the age range of 6.3 to 14.4 years. However, a weak 
positive skewness may reflect more children being older than 
expected under the assumption of perfect normality. Symptoms 
compatible with neonatal abstinence were reported in 41 of the 
exposed children, of whom 18 were diagnosed with NAS. Five 
children were reported without abstinence symptoms, and for 
11 children, there was no valid information regarding absti-
nence symptoms.
Mental health outcomes
Mental health outcomes are presented in Table 2. For the 
exposed group, the caregivers reported significantly higher 
scores of ADHD symptoms combined (P < .001) and Cohen’s 
d was large (d = 2.08). The SNAP-IV scores were high in areas 
of both inattention and hyperactivity/impulsivity. Caregivers 
also reported an increased number of symptoms associated 
with ASD, with the largest Cohen’s d in the subscale “social 
difficulties.” For the ASSQ, 21 of the 56 (37%) of the children 
had high scores (≥17) in the exposed group, compared with 5 
of the 162 (3%) in the reference group (odds ratio [OR] = 
17.44, 95% confidence interval [CI] = 6.1-49.6, P < .05). 
However, there was no significant difference in high ASSQ 
scores between the group of children placed into foster care 
before and those after 1 year of age (P = .083). The effect sizes 
for the outcome variables were in the range of 0.44 to 3.60. 
Effects for the mental health outcomes were above the thresh-
old for large effects. Mplus sensitivity analyses correcting for 
standard errors due to skewness in some variables confirmed 
that all differences were statistically significant (P < .001).
Predictors of mental health outcomes
Regression analyses were performed to evaluate possible pre-
dictors of mental health outcomes available in this study. Seven 
mental health measures were chosen as dependent variables, 
and predictors were age, gender, IQ, the presence or absence of 
NAS, and child placement outside of their biological home 
before or after the age of 1 year. The standardized regression 
coefficients for the independent variables are given in Table 3. 
IQ was a statistically significant factor in 5 of the 7 regression 
models, whereby higher IQ scores predicted lower levels of 
mental health problems. Furthermore, NAS was a significant 
predictor of the SNAP Inattention scale.
When analyzing the correlation between ASSQ Total score 
and SNAP, we found a moderate to strong correlation between 
high ASSQ scores and high SNAP scores, with the strongest 
Sandtorv et al 5
correlation between ASSQ Social difficulties and both SNAP 
Inattention (r = .702, P ≤ .01) and SNAP Hyperactivity/impul-
sivity (r = .714, P ≤ .01).
Discussion
In our hospital-based population of children prenatally exposed 
to substances, we found that exposed children had more symp-
toms associated with ADHD and ASD, compared with the 
reference group. Using the standardized instrument SNAP-IV 
and ASSQ, high symptom scores were obtained in the areas of 
inattention and hyperactivity/impulsivity, and in addition, the 
exposed children presented with an increased number of symp-
toms in all 3 ASSQ subscales. Of the available predictors of 
mental health outcomes in the exposed group of children, only 
the IQ could explain variances in some of the mental health 
scales and NAS only for ADHD/inattention problems. Gender, 
age, or early placement in an adopted home or foster care was 
not found to be predictive of mental health outcomes in the 
group of exposed children.
In line with earlier research in children prenatally exposed 
to substances,2,3 caregivers in this study reported an increased 
number of ADHD symptoms in the exposed group, with 
higher symptom scores for both hyperactivity/impulsivity and 
inattention, compared with the reference group. Attention def-
icit/hyperactivity disorder is a complex disorder and may result 
from processes involving both genetic and nongenetic factors.52 
A previous study found adults with substance use disorder to 
have a higher rate of ADHD symptoms and suggested ADHD 




gROUP (N = 171)
t P da
 MEAN (SD) MEAN (SD)
SNAP Combined 19.65 (9.06) 4.13 (5.37) 12.22 * 2.08
 SNAP Inattention 10.79 (4.63) 2.72 (3.49) 12.05 * 1.97
 SNAP Hyperactivity/impulsivity 8.86 (5.26) 1.42 (2.41) 10.31 * 1.82
ASSQ total 14.00 (7.98) 3.57 (4.51) 9.36 * 1.61
 ASSQ Social difficulties 7.74 (4.99) 1.47 (2.61) 9.07 * 1.57
 ASSQ Motor/tics/OCD 2.37 (2.22) 0.36 (1.06) 6.59 * 1.16
 ASSQ Autistic style 3.89 (2.65) 1.83 (2.06) 5.37 * 0.87
Abbreviations: ASSQ, Autism Spectrum Screening Questionnaire; OCD, obsessive–compulsive disorder; SD, standard deviation; SNAP, Swanson, Nolan, and Pelham 
Questionnaire, revision IV (SNAP-IV).
ad: Cohen’s d; t-test is corrected when Levene’s test shows unequal variances.
*P < .001.


















 β β β β β β β
Age −0.03 0.05 −0.09 0.01 0.01 −0.17 0.14
gender −0.22 −0.12 −0.26 0.02 0.06 0.06 −0.12
Early 
placementa
0.20 0.22 0.16 0.10 0.10 0.11 0.02
NAS 0.22 0.29* 0.12 0.09 0.09 0.22 −0.08
IQ −0.38** −0.48*** −0.22 −0.35* −0.40** −0.40** 0.02
R2 (adjusted) 0.23 (0.16) 0.28 (0.21) 0.17 (0.09) 0.12 (0.03) 0.15 (0.07) 0.18 (0.10) 0.04 (0.00)
Abbreviations: ASSQ, Autism Spectrum Screening Questionnaire; IQ, intelligence quotient; NAS neonatal abstinence syndrome; SNAP, Swanson, Nolan, and Pelham 
Questionnaire, revision IV (SNAP-IV).
Results from multiple regression analysis for SNAP Combined, SNAP Inattention, and SNAP Hyperactivity/impulsivity, and ASSQ Total, ASSQ Social difficulties, ASSQ 
Motor/tics/OCD, and ASSQ Autistic style. Relations are given by beta-weights (β) and model fit by explained variance.
aPlacement in adopted home or foster care before 1 year of age.
*P < .05; **P < .01; ***P < .001.
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as an independent risk factor for substance abuse.53 Therefore, 
it is possible that prenatally exposed children may be geneti-
cally predisposed to ADHD, which could explain the increased 
number of ADHD symptoms in this group of children.
Mean level of symptoms associated with ASD was increased 
in the exposed group of children, compared with the reference 
group, with more than 1 in 3 exposed children having high 
ASSQ scores, mainly on the “social difficulties” subscale. In 
children with prenatal alcohol exposure, an increased risk for 
both ADHD and ASD has been described.33 Autism spectrum 
disorder is characterized by symptoms of social impairment, as 
are other mental health disorders such as reactive attachment 
disorder (RAD), and therefore, diagnostic assessment is neces-
sary to distinguish between these disorders.41,54,55 Reactive 
attachment disorder may result from inadequate caregiving and 
can develop when a child’s caregiving environment fails to 
address the child’s care needs.41,54–56 This study did not demon-
strate any association between early placement in an adopted 
home or foster care and symptoms of ASSQ. We suggest future 
studies to evaluate possible associations between quality of the 
caregiving environment, as well as the timing, duration, and 
number of placements in foster care, and the development of 
mental health problems in prenatally exposed children.
In this study, IQ and NAS were the only predictors of men-
tal health outcomes. The protective effect of a higher IQ 
against mental health problems is in line with findings from 
previous studies investigating other risk factors such as prema-
turity57 and chronic illness.58 In this study, the presence of NAS 
was a predictor of later inattention problems, suggesting a 
potential vulnerability for neurodevelopmental disorders in 
children with NAS; however, more research is needed to inves-
tigate this further.5 Furthermore, children with overlapping 
symptoms of ADHD and ASD were found in the exposed 
group, which lends support to the suggested neurodevelop-
mental vulnerability in exposed children.
In summary, our study found that children prenatally 
exposed to substances presented with symptoms in more than 
one area of mental health problems. Although exposed chil-
dren may not necessarily fulfill the diagnostic criteria of a spe-
cific psychiatric disorder, they may present with a range of 
symptoms associated with ADHD and ASD. The extent of 
these symptoms strongly suggests a functional impact on daily 
living for many of these exposed children, and this calls for 
more attention focused on follow-up programs.
This study has limitations. We were unable to confirm the 
accuracy of the types of substances to which the fetus was exposed, 
based on information reported by the biological mothers. It is 
possible this resulted in an underestimation of the actual prenatal 
exposure to specific substances, e.g., alcohol. Previous studies 
reported some concurrent illicit polydrug use by mothers while 
undergoing OMT, emphasizing the complexity of accurately 
measuring actual exposure.59,60 In this study, it was not possible to 
ascertain whether the mothers had consumed alcohol, in addition 
to other substances during pregnancy, and we relied on obstetric 
and pediatric records, as well as reports from mothers. If there 
was confirmation or evidence of a greater number of single epi-
sodes of alcohol exposure, the children were excluded from this 
study, based on the known teratogenic effects of alcohol. Another 
limitation is that although nicotine exposure is a risk factor 
known to affect a child’s neurodevelopment,2,3 data on tobacco 
and nicotine use by mothers during pregnancy were not available 
in our study. Furthermore, the study design likely produced selec-
tion bias, as a hospital-based population tends to include the most 
severely affected children, which therefore has a major impact on 
the generalizability of the study findings. Also, it would have been 
useful to include mental health data collected from different set-
tings, such as from teachers’ reports, but due to ethical considera-
tions, it was not possible to invite teachers to participate in the 
study. Another limitation of this study was that we did not have 
information about IQ and foster care for the children in the refer-
ence group. As the reference group was drawn from a population 
with parents reporting having relatively good family economy, 
and about 50% reported having higher education, this could lead 
the reference group to consist of more well-adjusted children 
than the general population. This should be taken into account 
when interpreting the findings from this study.
Important strengths of this study are the relatively large 
population of children prenatally exposed to substances and the 
use of standardized, validated screening tools to assess mental 
health symptoms. Also, the reference group consisted of chil-
dren mainly from the same geographical area as the exposed 
group, which could contribute to the robustness of result com-
parability between the 2 groups, although there was no infor-
mation on prenatal substance exposure for the reference group.
Conclusions
Findings from our hospital-based study show that children 
prenatally exposed to substances presented with an increased 
number of symptoms associated with ADHD and ASD, com-
pared with the reference group. In light of increased mental 
health symptoms in children prenatally exposed to substances 
and referred to the hospital, early mental health assessment is 
suggested for this population. Moreover, caregivers should be 
educated on the range of symptoms associated with mental 
health problems for which exposed children are at risk. There 
is a need for increased awareness of, and further research on, 
the impact of prenatal substance exposure on mental health 
outcomes and functioning of exposed children within the fam-
ily, at school, and in the wider society.
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